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OVERVIEW 
This thesis focused on neurobiological changes in depression.  Part 1 reviewed 
research investigating the relationship between trauma in childhood, depression in 
adulthood and dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis.   The 
reviewed studies provided some evidence for associated changes to the HPA axis, however, 
there was inconsistency in findings as to whether this was linked to childhood trauma or 
depression in adulthood independently, or an interaction of the two.  The studies provided 
tentative evidence for a specific sub-type of depression, associated with a history of 
childhood trauma, but study heterogeneity and lack of replication mean further research is 
needed. 
Part 2 reported an investigation into the effects on hippocampus-dependent 
spatial memory of using valenced stimuli (neutral, negative) for both people with 
depression and healthy controls.  No influence of valence on memory performance was 
found, counter to the hypotheses.  However, some interesting effects of sex were found, 
warranting further investigation.   Potential reasons for the null results were explored, 
along with suggestions for further research to allow these reasons to be examined. This 
investigation formed part of a joint study with Line Sagfors (trainee clinical psychologist, 
UCL; Sagfors, 2017). 
Part 3 reflected on some of the methodological issues and learnings from the 
major research project, including adapting an existing spatial memory test and working 
with a mental health service and clinical population.  It explored the advantages of 
conducting joint DClinPsy research, both practical and emotional, and ended with some 
brief reflections on the challenges of the literature review. 
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PART 1: LITERATURE REVIEW 
 
Relationship between depression in adulthood, childhood 
trauma and HPA axis functioning   
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1 ABSTRACT   
Aims: Adults with depression show differences in hypothalamic-pituitary-adrenal 
(HPA) axis functioning, as do people with a history of childhood trauma.  This review aimed 
to explore evidence for an interaction between childhood trauma and depression in 
adulthood and its effects on basal activity and reactivity of the HPA axis, as well as possible 
moderators of this relationship.  
Method: A systematic review of PSYCHInfo, MedLine, and Embase was completed 
to identify peer-reviewed studies measuring depression, childhood trauma and HPA axis 
functioning up to August 2016.  Fifteen studies were included in the review.  
Results: There was heterogeneity within the studies in terms of design, 
methodology and analysis which made a comparison of studies problematic.  There was 
evidence to suggest childhood trauma and depression were associated with changes to the 
HPA axis, both in terms of basal activity and reactivity.  However, findings were inconsistent 
in terms of what these effects were and whether they were driven by a history of childhood 
trauma, depression or an interaction of the two.  The heterogeneity also made it difficult to 
assess the influence of potential moderators, including sex and co-morbid PTSD.  
Conclusions: Tentatively, the evidence pointed to a specific subtype of depression, 
associated with childhood trauma, one that may benefit from different treatment 
approaches.  Given the potential importance of this, there is an urgent need for replication 
studies in this area, structured to also explore potential moderators, to construct a more 
reliable picture that may then be used to influence interventions.    
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2 INTRODUCTION 
Stress occurs when a situation’s perceived demands outweigh perceived coping 
ability.  Stressful life events, including, but not limited to, physical and sexual assault, have 
been shown to be important predisposing factors in the development of depression, as well 
as triggers for specific depressive episodes (Kendler, Karkowski & Prescott, 1999).  What is 
more, experiencing trauma in childhood significantly increases the risk of developing 
depression in adulthood (Heim et al., 2000; Fergusson, Swain-Campbell, & Horwood, 2002; 
Cohen, Brown& Smailes, 2001).  Childhood trauma (CT) also influences the course of 
depression and treatment response (Nemeroff et al., 2003; Miniati et al., 2010).  Studies 
found 35% of people with depression had a history of CT, compared to 15% of healthy 
controls (Fellitti et al., 1998; Young, Abelson, Curtis & Nesse, 1997).  It is suggested this is 
due to the cumulative effects of the resultant stress response over time.  While the first 
episode of depression may have a clear trigger, triggers for further episodes become 
increasingly unclear. This suggests people with depression become increasingly sensitised 
to stress, reducing the threshold to trigger an episode (Post, 1992).   
Key neurobiological systems have been hypothesised to mediate this 
environmental vulnerability to depression following CT: the corticotropin-releasing factor 
(CRF) neuronal systems and the hypothalamic-pituitary-adrenal (HPA) axis.  These are 
activated when a stressful stimulus is encountered and regulate the response.  Initially, the 
release of CRF by the hypothalamus is stimulated.  This precipitates the release of 
adrenocorticotropic hormone (ACTH) by the pituitary gland, which in turn stimulates the 
release of cortisol by the adrenal cortex (see Whitnall, 1993 for a review).   Studies have 
shown CT can result in changes to CRF systems and HPA axis during development, altering 
their responses.  These changes persist into adulthood and are not seen in adults without 
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CT (Heim et al., 2000; Shea, Walsh, MacMillan, & Steiner, 2005; Mello, Mello, Carpenter, & 
Price, 2003).   
Adults with depression also show differences in HPA axis functioning (see Holsboer, 
2000 for a review).  There is evidence to suggest depression is associated with elevated 
cortisol levels, reduced feedback control, increased levels of corticotropin-releasing 
hormone (CRH) and alterations in response to CRH and ACTH (Gold, Drevets & Charney, 
2002).  However, findings are inconsistent.  This may reflect clinical characteristic 
heterogeneity between studies, for example severity of illness (Appelhof et al., 2016), but 
may also reflect the dependence of differences in HPA axis dysregulation on whether 
people also have a CT history (Harkness, Stewart & Wynne-Edwards, 2011).  Studies 
investigating the impact of CT on HPA axis functioning in adulthood have also been 
inconsistent.  Both hyper and hypo HPA axis activation of basal activity and stress reactivity 
have been found (for a review see Baes, Tofoli, Martins, & Juruena, 2012).    Taken 
together, these inconsistencies suggest it is necessary to consider the interaction of CT and 
depression in adulthood when investigating HPA axis dysregulation.  
 Measuring the HPA axis 
There is a need to distinguish effects on basal activity and HPA axis reactivity.  
Studies have used both to assess the impact of CT and depression.   
2.1.1 Basal activity  
Basal activity has a circadian rhythm.  Cortisol levels peak in the morning, and are 
at their lowest during night-time sleep (for a review see Walker, Terry & Lightman, 2010).  
Levels are typically measured in saliva or plasma at different time points, either across a 
day or a shorter space of time, and a mean calculated (e.g. Joyce et al., 2007).  More 
recently analysis of cortisol accumulated in hair has been used to retrospectively assess 
longer term levels (Hinkleman et al., 2013).  While some studies have found raised cortisol 
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levels with depression, this is not a consistent finding (see Steckler, Holsboer & Reul, 1999 
for a review).   
Basal HPA axis activity can also be reliably assessed using the cortisol awakening 
response (CAR; Mangold, Marino, & Javors, 2011).  CAR is the acute response of cortisol on 
waking, peaking after 30-45 mins (Pruessner et al., 1997; Clow, Hucklebridge, Stalder, Evans 
& Thorn, 2010).   Findings for depression are inconsistent.  Some studies have found 
enhanced CAR, (Bhagwagar, Hafizi, & Cowen, 2003, Vreeburg et al., 2004), others blunted 
(Stetler & Miller, 2005).  For CT in healthy controls, studies have shown enhanced CAR (Lu 
et al., 2013).  
2.1.2 Reactivity 
Impaired feedback inhibition is one way HPA axis reactivity is thought to be 
affected in depression (Pariante & Miller, 2001).  Cortisol produced when the HPA axis is 
active mediates the system.  There are two types of receptors, glucocorticoid receptors 
(GR) in the hypothalamus and pituitary gland, which are less sensitive to cortisol, and 
mineralcorticoid receptors (MR) in the hippocampus, which are more sensitive to cortisol.  
These ‘turn off’ the HPA axis when levels of circulating cortisol reach a certain level.  The 
two types of receptors are believed to serve different functions.  MR are believed to be 
involved in regulating daily circadian cortisol rhythms, and GR in the stress response (de 
Kloet, Vreugdenhil, Oitzl, & Joels, 1998; Young, Lopez, Murphy-Weinberg, Watson, & Akil, 
1997).   The balance between the two is therefore important for overall HPA axis 
functioning (de Kloet et al., 1998).   
The dexamethasone suppression test (DST) was the first test of feedback inhibition 
(Carroll, Curtis, & Mendels, 1976).  Failure to suppress endogenous cortisol release after 
administration of dexamethasone (a synthetic glucocorticoid) indicates reduced feedback 
sensitivity.  Dexamethasone has a greater affinity for GR, and is believed to indicate 
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reduced GR sensitivity.  People with depression show non-suppression with the DST, that is 
impaired feedback inhibition (e.g. Carroll et al., 1976).  However, the DST has been 
criticised for not being sufficiently sensitive or specific, and only measuring GR activity 
(Pariante et al., 2002).   
More recently, Pariante et al., (2002) developed a suppression test using 
prednisolone (PST).  The PST is considered to be more sensitive as prednisolone mimics 
cortisol more accurately than dexamethasone, and is believed to detect reduced GR and 
MR sensitivity (Pariante et al., 2002).   Studies using the PST with people with depression 
(Jurena et al., 2009; Jurena et al., 2010) have suggested no feedback impairment when 
compared with healthy controls.  The authors suggest differences in findings versus the DST 
are due to MR compensating for altered GR function (Jurena et al., 2010). 
HPA axis reactivity can also be measured by its response to stimulation with CRF 
(stimulating ACTH and subsequently cortisol) and ACTH (stimulating cortisol release 
directly).   
Challenge tests are regarded as the most sensitive way of measuring HPA axis 
activity (Heuser, Yassoridis & Holsboer, 1994; Ising et al., 2005; Watson, Gallagher, Smith, 
Ferrier & Young, 2006).  They combine stimulation with exogenous CRF and suppression 
using the DST (von Bardeleben & Holsboer, 1991).  Dexamethasone is administered one 
night and CRF the next morning.  After the injection of CRF, secretion of cortisol continues 
to be suppressed in healthy controls.  Depressed patients show an ‘escape’ from 
suppression (Heim et al., 2008a) with elevated cortisol and ACTH concentrations.  It has 
been suggested reduced GR sensitivity reduces suppression after dexamethasone is 
administered, increasing the effects of stimulation with exogenous CRF (von Bardeleben, & 
Holsboer, 1991; Heuser et al., 1994).  This test has the same drawbacks as the DST in terms 
of only assessing GR function.   
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Stressor tests use a variety of paradigms to assess the HPA axis response to current 
stress.  One of the best validated is the Trier Social Stressor Test (Kirschbaum, Pirke & 
Hellhammer, 1993).  This uses a naturalistic situation (giving a speech or completing 
arithmetic tests in front of others) to induce similar neurobiological system changes as 
encountering real-life stressors.  Healthy adults with a CT history have shown lower cortisol 
reactivity to the test (Carpenter et al., 2007). 
   PTSD: a potential moderator? 
Depression and anxiety disorders, including PTSD, often occur together for people 
with a CT history (Saunders, Villeponteaux, Lipovsky, Kilpatrick & Veronen, 1992).   CT can 
lead directly to PTSD, but also increases the risk of PTSD developing if trauma is 
experienced in adulthood (Bremner, Southwick, Johnson, Yehuda & Charney, 1993). PTSD 
has been found to be associated with changes to the HPA axis, including lower cortisol 
levels (Bierer et al., 2006; Carpenter et al., 2007; Heim, Newport, Bonsall, Miller & 
Nemeroff, 2001; Meewisse, Reitsma, de Vries, Gersons & Olff, 2007) and CAR (Yehuda, 
2006; Rohleder, Joksimovic, Wold & Kirschbaum, 2004; Wessa, Rohleder & Kirschbaum, 
2006).  In contrast to depression, with PTSD supersuppression has been found, suggesting 
enhanced feedback sensitivity (Stein, Yehuda, Koverola & Hanna, 1997; Yehuda, Halligan & 
Bierer, 2002; Yehuda et al., 1993; Yehuda, Boisoneau, Lowy & Giller, 1995).  An interaction 
of PTSD with CT has also been found in terms of increased cortisol levels in urine and 
feedback sensitivity (Lemieux & Coe, 1995; Stein et al., 1997). 
 Sex effects  
Depression is twice as prevalent in women than men (Young, 1998; Weiss, 
Longhurst & Mazure, 1999).  There may also be a stronger link with CT for women.   One 
study found 69% of female participants with a CT history had depression in adulthood, 
compared to 27% of males (Carmen, Rieker, & Mills, 1984).   Animal and human studies 
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suggest enhanced HPA axis stress reactivity in women (Ogilvie & Rivier, 1996; Handa, 
Burgess, Kerr & O'Keefe, 1994; Kant et al., 1983; Spinedi et al., 1994; Greenspan, Rowe, 
Maitland, McAloon-Dyke, & Elahi, 1993).  A hypothesised link to the sex steroids (Burgess & 
Handa, 1992) requires further research (Heim, Newport, Mletzko, Miller & Nemeroff, 
2008a).   The research may suggest different neurobiological changes in response to CT for 
men and women, in part accounting for women’s greater vulnerability to depression (Weiss 
et al., 1999).   
 Previous reviews   
There have been several reviews in this area. Two recent ones looked more 
generally at CT’s impact on the HPA axis and the relationship with later psychopathology, 
but neither included a systematic review of literature relating to depression (Struber, 
Struber & Roth, 2014; Nemeroff, 2016).  Heim et al’s (2008a) review looked at the 
relationship between CT, depression and HPA axis dysregulation, but restricted itself to the 
work of their own group.  Baes et al. (2012) conducted a systematic review of GR and MR 
dysregulation studies only.  They also included studies looking solely at people with 
depression and solely at healthy people with CT histories, as well as those investigating an 
interaction of the two. To the author’s knowledge, there has been no systematic review 
looking at how the interaction of depression and CT affects measures of HPA axis 
functioning.     
2.4.1 Aims of this review 
The aim was to provide a systematic review of the literature investigating the 
relationship between CT, depression in adulthood and HPA axis functioning.  The primary 
aim was to look at evidence for an interaction between CT and depression in adulthood, 
and its effect on basal cortisol levels and reactivity of the HPA axis.  The secondary aim was 
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to consider evidence for potential moderating factors on any relationship, including sex, 
depression severity, types of trauma and co-morbid PTSD.  
 
3 METHOD 
 Literature search and selection 
A literature search was conducted using three electronic databases (Medline, 
PSYCHinfo and EMBASE) on 31st August 2016.  An initial consideration of articles in this area 
suggested the terms for the systematic search (Table 1). 
Table 1.  
Literature search terms 
 
 
 
 
 
 
First duplicates were excluded.  Abstracts were initially screened, then a full text 
search conducted for the remaining articles.  Original research, published in English, 
involving human adults and a clinical group with current depression as the primary 
organising diagnosis, were included.   Studies were only included if they investigated an 
interaction of the three key variables: cortisol or HPA axis activity; CT; and current 
depression status.  Review papers were excluded but reference lists of ten relevant reviews 
identified were hand checked.   
Literature search terms 
HPA axis History of childhood trauma Depression 
Cortisol 
Hydrocortisol 
Glucocorticoid* 
Hypothalamic pituitary 
adrenal 
 
Child* abuse 
Childhood trauma 
Early life experiences 
Early life stress  
 
Depress* 
MDD 
 
*truncated to allow for multiple endings of words 
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 Assessment of methodological quality  
Methodological quality was assessed using the Crowe Critical Appraisal Tool (CCAT; 
Version 1.4) (Crowe & Sheppard, 2011).  The CCAT is a validated tool with good inter-rater 
reliability (.74; Crowe, Sheppard & Campbell, 2012).  It provided a framework to assess the 
studies papers under eight headings, with a total score of 40 (five marks for each section).  
There were no norms for a ‘good’ score.  For this review, a core percentage score was 
calculated from marks for Design, Sampling, Data Collection and Results sections.   
 Analysis  
The qualitative analysis primarily focused on findings of the studies in terms of the 
relationship between depression, CT and measures of HPA axis activity/reactivity.  
Reference to comparator groups was made where possible, even where this was not the 
primary focus of the study.  Any additional analysis included in the studies, for example 
levels of PTSD symptomology, was included only where this related to the review aims. 
 
4 RESULTS 
 Study selection 
The search identified 357 citations once duplicates were deleted (Figure 1). The 
review of titles and abstracts resulted in 30 full-text articles being retrieved. No additional 
articles were identified through the hand search of key review article references lists.  
Fifteen articles (published from 2000 to 2016) met the inclusion criteria and were included 
in the qualitative synthesis. 
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Figure 1: Flow chart for qualitative synthesis study selection 
 
 Study quality 
The range of total CCAT scores was 50% to 75% (mean = 63%).  For core CCAT 
scores, the range was 50% to 70% (mean = 62%; median = 60%).  Table 2 gives the 
breakdown of each studies’ core score, along with an assessment of strengths and 
weaknesses.  The core scores were included in the qualitative synthesis summary (Table 4). 
 
 
 
Figure 1: flow chart for the selection of studies for the qualitative synthesis 
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Table 2 
Breakdown of core CCAT score with strengths and weaknesses by study 
Study 
 
Core score and breakdown Strengths  Weaknesses 
Hinkleman et 
al., 2013 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
3 
3 
3 
3 
12  
(60%) 
 
✓ 4 groups 
✓ Male and female sample and 
sex included in analysis 
✓ PTSD measured and used in 
analysis 
✓ Short and long-term 
measures of cortisol 
 
 No power analysis or effect sizes 
 No demographic breakdown 
 No analysis by depression 
severity 
 No analysis by CT subtype 
 Small CT only group 
 
Joyce et al., 
2007 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
2 
3 
4 
3 
12  
(60%) 
 
✓ Male and female sample and 
sex included in analysis 
✓ Subtypes of CT measured 
and used in analysis 
✓ Parental bonding measured 
and used in analysis 
✓ Good sample size 
✓ Depression severity included 
in analysis 
 
 2 groups – no CT only or HC 
 No power analysis or effect sizes 
 Unclear treatment of PTSD 
Lopes et al., 
2010 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
 
3 
2 
3 
4 
12  
(60%) 
✓ DHEAS measured as well as 
cortisol 
✓ PTSD measured and used in 
analysis 
✓ Depression severity included 
in analysis 
 
 3 groups – no CT only 
 Female only sample No power 
analysis or effect sizes 
 Relatively small sample size 
 No analysis by CT subtype 
 
Peng et al., 
2004 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
 
3 
3 
3 
3 
12  
(60%) 
✓ 4 groups 
✓ Male and female sample 
✓ Measured depression 
severity and used in analysis 
✓ Excluded co-morbid PTSD 
✓ Depression severity included 
in analysis 
 
 No power analysis or effect sizes 
 No demographic breakdown 
 No sex analysis  
 No analysis by CT subtype 
 
Lu, Goa, 
Huang, Li & 
Xu, 2016 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
 
4 
3 
4 
4 
14  
(70%) 
✓ 4 groups 
✓ Males and female sample 
and sex included in analysis 
✓ Excluded co-morbid PTSD 
✓ Analysis by CT subtype 
 
 
 No power analysis or effect sizes 
 Depression severity not included 
in analysis 
 
Newport, 
Heim, 
Bonsall, 
Miller & 
Nemeroff, 
2004 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
3 
3 
3 
3 
12  
(60%) 
✓ 4 groups 
✓ PTSD measured and used in 
analysis 
✓ Stress in adulthood 
measured 
 
 No power analysis or effect size 
 Female only sample 
 Relatively small sample 
 Stress in adulthood not included 
in analysis 
 Depression severity not included 
in analysis 
 
Baes, 
Martins, 
Tofoli & 
Jurena, 2014 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
 
3 
2 
4 
3 
12  
(60%) 
✓ Male and female 
✓ Measured MR and GR 
activity separately 
✓ Depression severity included 
in analysis 
 
 No power analysis or effect sizes 
 No sex analysis 
 3 groups – no CT only  
 Depression only group small 
 PTSD not included in analysis 
 Did not exclude bipolar 
 
Jurena et al., 
2009 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
 
3 
3 
3 
3 
12  
(60%) 
✓ Male and female 
✓ Analysis by treatment 
response 
✓ Used PST – more accurate 
measure 
✓ Depression severity included 
in analysis 
 
 
 No power analysis or effect sizes 
 Only 3 groups 
 No sex analysis 
 Small depression only group 
 Inpatient clinical population 
 PTSD present but not separately 
analysed 
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Study 
 
Core score and breakdown Strengths  Weaknesses 
Heim et al., 
2000 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
 
3 
3 
4 
3 
13  
(65%) 
✓ Power analysis included 
✓ Validated stressor test used 
✓ Stress in adulthood 
measured 
 Female only 
 No effect sizes 
 Relatively small sample 
 Co-morbid PTSD present but not 
separately analysed 
 Depression severity and stress in 
adulthood not included in 
analysis 
 No demographic breakdown 
 Did not look at subtypes of 
abuse 
 
Heim et al., 
2002 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
 
3 
3 
4 
4 
14  
(70%) 
 
✓ Power analysis included 
✓ Validated stressor test used 
✓ PTSD, depression severity, 
stress in adulthood included 
in analysis 
 Female only 
 No effect sizes 
 Relatively small sample 
 Did not look at subtypes of 
abuse 
 
Brand et al., 
2010 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
 
2 
2 
4 
3 
11  
(55%) 
✓ PTSD included as moderator 
✓ Good overall sample size 
✓ Measured stress in 
adulthood 
 Female (mothers) only 
 Only two groups – no CT only or 
healthy control groups 
 No power analysis or effect sizes 
 Uneven group sizes 
 Non-standardised stressor test 
used 
 Did not look at abuse subtypes  
 
Suzuki, Poon, 
Papdopoulos, 
Kumari & 
Cleaere, 
2014 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
3 
3 
4 
4 
14 
(70%) 
✓ Male and female sample 
✓ 4 groups 
✓ Effect sizes given 
✓ Specific trauma based 
stressor test 
✓ Used CT subscales in 
analysis 
✓ Inpatient and outpatient 
populations analysed 
separately 
✓ Measured PTSD, depression 
severity and used as 
covariates  
 
 No power analysis  
 Male sample relatively small 
 Not a validated stressor test 
 No sex analysis 
Heim, 
Newport, 
Bonsall, 
Miller & 
Nemeroff, 
2001 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
3 
2 
4 
3 
12  
(60%) 
✓ 4 groups 
✓ Measured PTSD and current 
SLEs 
 No power analysis or effect sizes 
 Female only sample 
 Relatively small sample 
 Did not analyse PTSD and SLEs 
separately 
 Did not look at subtypes of 
abuse 
 Depression severity not included 
in analysis 
 
Heim, 
Mletzko, 
Purselle & 
Nemeroof, 
2008b 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
4 
3 
4 
3 
14 
(70%) 
✓ 4 groups 
✓ Power analysis included 
✓ Measured PTSD and used as 
covariate in analysis 
✓ CT subscales analysed 
✓ Stress in adulthood 
measured 
 
 Males only 
 Relatively small sample 
(depression only = 6) 
 No effect sizes 
 Depression severity and stress in 
adulthood not analysed 
Watson et al., 
2007 
 
 
Design (/5) 
Sampling (/5) 
Data collection (/5) 
Results (/5) 
Total (/20) 
 
2 
2 
3 
3 
10  
(50%) 
✓ Male and female sample 
✓ Types and levels of CT 
analysed 
✓ Limited sex analysis 
✓ Measured family history, 
limited analysis 
 
 
 3 groups (depression, bipolar, 
HC) 
 Clinical group analysed together 
 Restricted separate depression 
group analysis 
 No power analysis or effect sizes 
 No assessment of PTSD 
 Control group not specific to 
study 
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 Characteristics of the studies 
4.3.1 Study samples 
There were differences in study samples.  In terms of sex: eight used men and 
women; six women only; and one men only.  In terms of numbers of participant groups: 
nine had four groups (current depression and CT history; CT without current depression; 
current depression without a CT history; and healthy controls with no history of depression 
or CT); three had three groups (no CT only group); and two had two groups (depression 
groups only; see Table 4). 
4.3.2 Trauma measures 
Eight studies used the Childhood Trauma Questionnaire (CTQ; Pennebaker & 
Susman, 1988).  Other trauma measures used were: Parental Bonding Instrument (PBI; 
Parker, Tupling, & Brown, 1979); Early Trauma Inventory (ETI; Bremner, Vermetten & 
Mazure, 2000), Childhood Experience of Care and Abuse Questionnaire (CECA-Q; Bifulco, 
Bernazzani, Moran & Jacobs, 2005).  Four studies also used measures of current stress and 
life events: Life Events Survey (LES; Sarason, Johnson & Siegel, 1978); Perceived Stress Scale 
(PSS; Cohen, Kamarck & Mermelstein, 1983) and Daily Hassles Scale (DHS; Kanner, Coyne, 
Schaefer & Lazarus, 1981) (See Table 4). 
4.3.3 Clinical measures 
The most common measure of depression symptomology was the Hamilton 
Depression Rating Scale (HDRS; Hamilton, 1960), used by 12 studies.  Two used the Beck 
Depression Inventory (BDI-II; Beck, Steer & Brown, 1996) and one the Quick Inventory on 
Depression Symptomology (QIDS-SR; Rush et al., 2003).  Three studies also measured PTSD 
symptomology using the PTSD Checklist Civilian Version (PCL-C; Blanchard, Jones-
Alexander, Buckley & Forneris, 1996) and the Clinician Administered PTSD Scale (CAPS; 
Blake et al., 1995) (See Table 3). 
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4.3.4 Measures of HPA axis 
Several different measures of the HPA axis were used, with the number of studies 
using each summarised in Figure 2.  To facilitate the qualitative synthesis, studies were 
grouped according to the primary method of HPA axis assessment.   
 
 
 
 
 
 
 
 
 
4.3.5 PTSD and other co-morbidity  
Table 3 details whether samples included participants with co-morbid PTSD and 
other psychiatric disorders, if symptomology was measured and whether they were 
included in the analysis.   
 Synthesis 
Table 4 provides a summary of the studies.  The table and synthesis are grouped by 
the method used to measure the activity/reactivity of the HPA axis as detailed in Figure 2. 
  
                                                                                                                                                                                                                         
 
 
 
 
 
 
 
 
 
 
Figure 2: grouping of studies for qualitative synthesis according to the primary method of 
assessing the HPA axis used 
 
Basal HPA axis activity 
(4) 
Cortisol reactivity 
(11) 
Salivary 
cortisol 
(2) 
Hair 
cortisol 
(1) 
CAR 
(1) 
Stressor 
(4) 
Suppression 
(4) 
Total studies 
(15) 
Challenge 
(2) 
Stimulation 
(1) 
Figure 2: Grouping of studies for qualitative synthesis according to the primary 
method f assessing th  HPA axis used 
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Table 3 
Details of presence, measurement and inclusion in analysis of co-morbid PTSD and other 
psychiatric disorders. 
Authors 
 
Co-morbid PTSD Other co-morbid disorders 
Hinkleman et al., 2013 
 
Present 
Included in analysis 
 
Some excluded 
Joyce et al., 2007 
 
Not stated Some excluded 
Lopes et al., 2010 
 
Present. Symptoms measured. 
Included in analysis 
 
Axis I excluded 
Peng et al., 2004 
 
Excluded Axis I and II excluded 
Lu et al., 2016 
 
Excluded All other Axis I and II excluded 
Newport et al., 2004 
 
Present. Symptoms measured. 
Included in analysis 
 
Some excluded (psychosis, bipolar 
disorder) 
Baes et al., 2014 
 
Present 
Not included in analysis 
Psychotic symptoms excluded 
Other Axis I allowed but not 
separated out 
 
Jurena et al., 2009 Present 
 Only analysed as part of Axis I 
disorders, not separately 
 
Some excluded 
Other Axis I and II allowed 
   
Heim et al., 2000 
 
Present 
No separate analysis 
 
Psychosis, bipolar, eating 
disorders excluded 
Heim et al., 2002 
 
Present 
No separate analysis 
 
Psychosis, bipolar, eating 
disorders excluded 
Brand et al., 2010 
 
Present 
Included in analysis 
 
Psychosis, bipolar disorder 
excluded 
Suzuki et al., 2014 
 
Present 
Separated in analysis 
 
Not excluded  
Anxiety measured  
Heim et al., 2001 
 
Present 
No separate analysis 
 
Psychosis, bipolar, eating 
disorders excluded 
Heim et al., 2008b 
 
Present. Symptoms measured. 
Used as covariate 
 
Psychosis, bipolar, eating 
disorders excluded 
Watson et al., 2007 
 
Not stated Present – bipolar disorder group 
 
 
 
 
 
 
Table 4 
Summary of studies for qualitative synthesis  
Authors Aim Sample Age (M± 
SD; years) 
Clinical 
measure 
Trauma 
measure 
Cortisol 
measure/paradigm 
Statistical 
analysis 
Core 
quality  
Summary of main results 
    1. BASAL ACTIVITY     
Hinkleman et 
al., 2013 
To examine retrospective cortisol 
levels according to the presence or 
absence of childhood trauma in 
patients with depression and 
healthy control subjects 
 
N = 84 
 
    = 53         = 31 
 
 
         = 24           = 19 
    
         = 7             = 34 
 
41.7 ±10.5 
 
HDRS CTQ Diurnal salivary cortisol (4 
time points) 
Hair cortisol 
Mixed ANOVA 
 
60% Hair and salivary cortisol: 
 
          =           <           =  
 
 
 
 
Joyce et al., 
2007 
To examine whether childhood 
variables including physical and 
sexual abuse, influences plasma 
cortisol levels in major depression 
 
N = 192 
 
    = 108       = 84 
 
    
        = 34           = 155 
 
31.8± 11.3 
 
HDRS 
MADRS 
MSE 
PBI Mean afternoon saliva (5 
time points) 
One-way 
ANOVA 
Multiple linear 
regression 
60% Cortisol: 
 
<  
Lopes et al., 
2010 
To investigate the effects of a 
history or early life stress and 
PTSD symptoms on HPA axis 
function over the day for women 
with recurrent MDD matched with 
healthy controls 
 
    
      = 53        
 
 
        = 16           = 22 
 
        = 15            
 
41.06
±6.46 
 
39.73
±10.12 
 
37.07
±5,64 
 
BDI 
PCL-C 
CTQ Diurnal salivary cortisol 
levels (3 measures) 
Salivary DHEAS 
 
One-way 
ANOVA 
Post-hoc group 
analyses 
60% Cortisol and DHEAS: 
 
=           <      
Peng et al., 
2004 
To explore the impact of 
childhood neglect on HPA axis 
functioning, dysfunctional 
attitudes and the severity of 
depression 
N= 109 
    
     = 51            = 58 
 
    
          = 28           = 30 
 
          = 22           = 29 
 
28.87
±6.28 
 
28.37
±8.27 
 
28.37
±5.28 
 
27.87
±4.28 
 
HDRS 
SSRS 
DAS 
CTQ CAR 
∆ salivary cortisol 
Two-way 
ANOVA 
Post-hoc group 
analyses 
Correlational 
analysis 
 
 
 
60% ∆ salivary cortisol: 
 
=            =           > 
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Authors Aim Sample Age (M± 
SD; years) 
Clinical 
measure 
Trauma 
measure 
Cortisol 
measure/paradigm 
Statistical 
analysis 
Core 
quality 
Summary of main results 
    2.REACTIVITY      
Lu et al., 2016 To examine HPA axis activity with 
respect to histories of childhood 
trauma in both depression and 
normal controls 
N=80 
 
    = 46              = 34 
 
 
          = 18           = 17 
 
         = 22            = 23 
 
23.70
±4.13 
 
23.90
±3.75 
 
21.50 
±3.91 
 
21.80
±3.01 
 
HDRS 
ZSRDS 
CTQ CAR: 
∆ salivary cortisol 
Suppression: DST (low 
dose) 
Suppression of salivary and 
plasma cortisol 
Mixed repeated 
measures 
ANCOVA 
Correlational 
analysis 
70% CAR: 
 
= 
 
= 
 
> 
 
> 
 
DST: 
 
< 
 
< 
 
< 
 
Newport et al, 
2004 
To administer standard and low 
dose dexamethasone to abuse 
survivors with and without 
depression or PTSD to help 
elucidate the neurobiological 
mechanisms whereby childhood 
trauma results in a persistent 
vulnerability to a psychiatric 
disorder 
 
     
    = 64       
 
 
         = 16           = 10 
       
         = 19          = 19 
 
32.40
±7.80 
 
33.90
±8.30 
 
33.30 
±6.40 
 
28.50
±6.90 
 
HDRS 
CAPS 
ETI 
LES 
PSS 
Suppression: DST 
(standard and low dose) 
Suppression of plasma 
ACTH and cortisol 
 
Two-way 
ANCOVA with 
post hoc Tukey-
Kramer 
pairwise 
comparisons 
60% Standard dose: 
=        =           =           = 
 
Low dose:  
 
          >           =           =  
 
 
Baes et al., 
2014 
To better understand the role of 
early life stress on MR function in 
depressive patients  
N = 30 
   
    = 15              = 5 
(data not available 
for control group) 
 
          = 13           = 7 
 
          = 10          
 
 
39.50
±2.70 
 
37.40
±4.30 
 
29.40
±8.00 
 
HDRS CTQ CAR after suppression 
with: 
Placebo (P) 
Dexamethasone (D) 
Fludocortisone (F) 
Suppression of salivary 
cortisol 
 
Mixed repeated 
measure one-
way ANOVA 
with Tukey 
corrected post 
hoc tests 
Correlational 
analysis  
 
 
60% P, D, F: 
 
 =           = 
 
             D>P,  F>P,  D>F 
 
             D>P,  P=F,  D=F 
 
             D>P,  D>F,  P=F 
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Authors Aim Sample Age (M± 
SD; years) 
Clinical 
measure 
Trauma 
measure 
Cortisol 
measure/paradigm 
Statistical 
analysis 
Core 
quality  
Summary of main results 
Jurena et al., 
2009 
To understand more about the 
role of the HPA axis in severe 
depression, specifically in the 
aetiology of treatment resistance 
N = 91 
 
     = 51            = 58 
 
          = 31           = 14 
 
          = 46            
 
50.90     
±1.50 
 
46.50
±2.10 
 
RLCQ 
HDRS 
MADRS 
IDS 
BDI-II 
BAI 
CECA Suppression: PST 
Suppression of salivary 
cortisol 
 
Mixed repeated 
measures 
ANOVA 
Correlational 
analysis 
60% Suppression: 
 
  =           =          
Heim et al., 
2000 
To determine whether early life 
stress results in a persistent 
sensitisation of the HPA axis to 
mild stress in adulthood, thereby 
contributing to vulnerability to 
psychopathological conditions 
 
    
     = 49   
 
 
          = 13           = 10 
 
          = 14           = 12 
 
32 
95% CI 
27-36 
 
34.60 
95% CI  
29-41 
 
30 
95% CI  
27-33 
 
29 
95% CI  
24-34 
 
HDRS ETI 
LES 
DHS 
Stressor: TSST 
∆ plasma ACTH and 
cortisol 
Two-way 
repeated 
measure 
ANCOVA 
Post-hoc 
contrasts  
65% ACTH: 
 
          =           >          = 
 
Cortisol:  
 
           >          =          =        
 
 
Vs  
 
↑ ACTH  ↑ Cortistol 
  ↑ ACTH  = Cortistol 
= ACTH  = Cortistol  
Heim et al., 
2002 
To evaluate the relative role of 
early adverse experience vs stress 
experience adulthood in the 
prediction of neuroendocrine 
stress reactivity in women 
 
     
     = 49   
 
 
          = 13           = 10 
 
          = 14           = 12 
 
32 
95% CI 
27-36 
 
34.60 
95% CI  
29-41 
 
30 
95% CI  
27-33 
 
29 
95% CI  
24-34 
 
HDRS ETI 
LES 
DHS 
Stressor: TSST 
Maximum plasma ACTH 
and cortisol 
Multiple linear 
regression 
analyses 
70% Predictors of maximum ACTH 
(35% of var): 
Age (-) 
Childhood abuse history (+) 
No. childhood trauma 
experiences (-) 
No. adult trauma experiences 
(+) 
Depression symptoms (+) 
Childhood trauma x adult 
trauma (+) 
Predictors of maximum 
cortisol (18% of var): 
History of childhood abuse (+) 
No. childhood trauma 
experiences (-) 
Daily life hassles (-) 
Depression symptoms (+) 
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Authors Aim Sample Age (M± 
SD; years) 
Clinical 
measure 
Trauma 
measure 
Cortisol 
measure/paradigm 
Statistical 
analysis 
Core 
quality 
Summary of main results 
Brand et al., 
2010 
To investigate the association 
between maternal history of child 
abuse and maternal cortisol levels 
in a clinical sample of postpartum 
women and to explore whether 
depressive symptoms and 
stressful life events moderate this 
relationship 
 
 
     
     = 126 
 
 
     
          = 38           = 88 
 
34±4.00 BDI-II CTQ Stressor: Specific 
infant/mother stressor 
paradigm 
∆ salivary cortisol 
ANCOVA 55% Baseline cortisol: 
 
= 
 
Post stressor cortisol: 
 
< 
 
∆ cortisol: 
 
↓ 
= 
 
Suzuki et al., 
2014 
To examine stress reactivity in 
individuals with and without a 
history of childhood trauma and 
with or without depression by 
measuring cortisol responses to 
the passive viewing of stressful 
images, including images relevant 
to childhood trauma 
 
N = 80 
      
     =   52           = 28  
 
        
         = 20           = 18 
 
 
          = 17           = 24 
 
52.10
±12.00 
 
51.70
±10.80 
 
44.30 
±12.50 
 
45.30
±13.70 
 
QIDS-SR CTQ Stressor: Specific 
psychosocial stressor test 
∆ salivary cortisol 
One-way 
repeated 
measures 
ANOVA plus 
post hoc 
analysis 
Three-way 
mixed ANOVA 
Two-way 
ANCOVA 
 
70% Stress reactivity: 
 
          >            =         = 
Heim et al., 
2001 
To evaluate pituitary-adrenal 
responses to standard HPA axis 
challenge tests in adult female 
survivors of childhood abuse with 
and without major depressive 
disorder 
 
    
     = 66  
 
 
          = 15           = 11 
 
          = 20           = 20 
 
32.60
±6.50 
 
34.50
±6.90 
 
 31.10 
±6.40 
 
27.80
±6.80 
 
HDRS ETI 
LES 
DHS 
Stimulation: CRF  
∆ plasma ACTH and 
cortisol 
Three-way 
repeated 
measure 
ANOVA with 
post hoc 
contrasts 
60% CRF stimulation vs     : 
 
  ↑ ACTH resp. 
  ↓ ACTH resp. 
  ↓ ACTH resp. 
 
      ↓ stim. cortisol levels 
      ↓ stim. cortisol levels 
      = stim. cortisol levels 
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Authors Aim Sample Age (M± 
SD; years)) 
Clinical 
measure 
Trauma 
measure 
Cortisol 
measure/paradigm 
Statistical 
analysis 
Core 
quality  
Summary of main results 
Heim et al., 
2008b 
To determine the impact of 
childhood trauma on 
dexamethasone/CRF test results in 
patients with major depressive 
disorder 
      
     = 49  
 
 
          = 15           = 6 
 
          = 14           = 14 
    
 
32.30
±8.70 
 
30.00
±9.50 
 
 31.40 
±8.00 
 
29.10
±9.00 
 
HDRS 
CAPS 
ETI 
LES 
Challenge: DST/CRF 
stimulation 
∆ plasma ACTH and 
cortisol 
One-way 
ANCOVA 
Post hoc 
analysis  
Two-way 
repeated 
measure 
ANCOVA  
Correlational 
analysis 
70% Cortisol and ACTH 
response: 
 
> 
> 
 
Watson et al., 
2007 
To examine the relationship 
between early adverse life 
experience, family history and HPA 
axis function for patients with 
MDD and bipolar disorder 
N = 58 
    
     =   11           =  19 
 
(data not available 
for control group) 
 
Patients:  
MDD = 10 
BD = 30 
Divided into high 
(EN+) and low (EN-) 
emotional neglect  
        = 28 
 
 
MDD 51.90 
±9.50 
 
BD 47.50 
±7.20 
HDRS CTQ 
 
Challenge: DST/CRF 
stimulation 
∆ plasma ACTH and 
cortisol 
Mann-Whitney 
U and Krushkal-
Wallis H test 
Fishers Exact 
test 
50% Cortisol response: 
 
Total patients: 
EN- > EN+ = 
 
MDD: 
EN- = EN+ 
 
BD: 
EN- > EN+ 
Sample: 
            Depression and history of childhood trauma 
            Depression only 
            History of childhood trauma only 
            Healthy controls 
 
Results: 
 = no statistical difference 
< statistically significantly lower 
> statistically significantly higher  
↑ statistically significant increase 
↓ statistically significant decrease 
 
Clinical measures:  
HDRS = Hamilton Depression Rating Scale 
MADRS = Montgomery Asberg Depression Rating Scale 
MSE = Mental State Examination for Melancholia 
BDI = Beck Depression Inventory 
ZSRD = Zung Self-Rating Depression Scale 
QIDS-SR = Inventory on Depression Symptomology  
PCL-C = PTSD Checklist Civilian Version 
CAPS = Clinician Administered PTSD Scale 
Cortisol measures: 
CAR = Cortisol Awakening Response 
DHEAS = Dehydroepiandrosterone 
PST = Prednisolone Suppression Test 
DST = Dexamethasone Suppression Test 
TSST = Trier Social Stressor Test 
 
Trauma measures: 
CTQ = Childhood Trauma Questionnaire 
PBI = Parental Bonding Instrument 
ETI = Early Trauma Inventory 
LES = Life Events Survey 
PSS = Perceived Stress Scale 
CECA-Q = Childhood Experience of Care and Abuse Questionnaire 
SSRS = Social Support Rating Scale 
DAS = Dysfunctional Attitudes Scale 
RLCQ = Recent Life Changes Questionnaire 
DHS= Daily Hassles Scale 
 
 
 
4.4.1 Basal activity  
a) Cortisol level 
Three studies looked solely at cortisol levels (Winkelman et al., 2013; Joyce et al., 
2007; Lopes et al., 2010).  Another two included data for baseline cortisol levels as part of 
reactivity studies (Heim et al., 2001; Brand et al., 2010).  Overall, studies found a reduction 
in cortisol levels when groups were compared to healthy controls.  However, they differed 
in whether this reduction was associated with CT or depression.   
Both Hinkleman et al. (2013) and Joyce et al. (2007) found CT was associated with a 
reduction in cortisol relative to healthy controls, as did Heim et al. (2001).  In Hinkleman et 
al.  (2013), the same reduction was observed for both diurnal salivary cortisol and hair 
cortisol (allowing a retrospective analysis of accumulated cortisol levels over several 
months).  There was no interaction between depression and CT and no effect of 
depression, an effect that held when two participants with co-morbid PTSD were removed.   
Joyce et al. (2007) looked at mean afternoon cortisol levels for a sample with 
depression; there was no healthy control group or CT only group.  Participants with 
depression and a CT history had reduced cortisol levels when compared to the depression 
only group.  There was no effect of depression severity, which could be seen as supporting 
the above, but there was an association with a melancholic subtype (observable 
retardation and agitation assessed using the Mental State Examination for Melancholia; 
Parker & Hadzi-Pavlovic, 1996).  An analysis by CT subtype and parental bonding showed 
this effect held for both childhood sexual and physical abuse, and maternal affectionless 
control (low maternal care plus high maternal protection).  A multiple regression found 
maternal affectionless control, childhood physical abuse, childhood sexual abuse, 
melancholia and sex explained 22% of the variance in afternoon cortisol levels.  Maternal 
affectionless control was the best predictor, followed by physical abuse, sexual abuse and 
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melancholia.  Sex was not a significant predictor (Joyce et al., 2007).   Heim et al. (2001) 
found lower baseline cortisol levels for groups with a CT history, whether or not they had 
current depression, supporting the above. 
In contrast, Lopes et al. (2010) found depression was associated with reductions in 
both cortisol and dehydroepiandrosterone (DHEAS; an adrenal steroid that antagonises 
various stress-related effects of glucocorticoids on peripheral tissues and the hippocampus 
and is therefore thought to have protective biological actions).  There were no additional 
effects of CT.  Both depression and PTSD symptomology were negatively correlated with 
cortisol levels and DHEAS.  Brand et al. (2010) also found, for mothers with a history of 
depression, no difference in baseline cortisol between those with and without a CT history, 
although there was no control group in this study.  Maternal depression symptoms, 
stressful life events and a history of PTSD did not moderate the relationship between a CT 
history and baseline cortisol.  However, it should be noted that the mothers’ levels of 
current depression symptomology were not high, and a number (not specified) would not 
have met diagnostic criteria for current depression (Brand et al., 2010).   
The effects of co-morbid PTSD were unclear.  While Hinkleman et al. (2013) and 
Brand et al. (2010) found no effect of removing those with PTSD, Lopes et al. (2010) did 
find a correlation between PTSD symptoms and cortisol levels. 
Methodological differences, in addition to cortisol measure used, made a 
comparison of these studies difficult, although overall each study scored 60% on the core 
CCAT quality assessment.  Hinkleman et al. (2013) and Joyce et al. (2007) used male and 
female samples, while Lopes et al. (2010), Heim et al. (2001) and Brand et al. (2010) used 
female participants only.  It is worth noting, however, neither Hinkleman et al. (2013) nor 
Joyce et al. (2007) found a sex effect on cortisol levels.  While Hinkleman et al. (2013), 
Lopes et al. (2010) and Brand et al. (2010) assessed additional effects of PTSD, PTSD was 
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not included in the analysis or participant description in Joyce et al. (2007).  Heim et al. 
(2001) provided information about numbers in each group meeting PTSD diagnostic criteria 
(14/15 in the group with depression and CT history versus 4/11 for the CT only group), but 
performed no subanalysis.   
 
 
 
 
 
b) Cortisol Awakening Response (CAR) 
One study solely assessed basal activity using the CAR (Peng et al., 2014) and two in 
conjunction with other tests (Baes et al., 2014; Lu et al., 2016).  Peng et al. (2014) and Lu et 
al. (2016) found CAR hyperreactivity was associated with CT but not depression when 
groups with a CT history (with or without depression) were compared to healthy controls 
and groups with depression only.  Hyperreactivity increased with CTQ scores (Peng et al., 
2014; Lu et al., 2016), but not depression severity (Peng et al., 2014). The depression only 
group showed hyporeactivity when compared to healthy controls, consistent with previous 
studies into effects of depression on the CAR (Gold et al., 2002).  The sample sizes of both 
studies precluded analysis by trauma type.  Both specifically excluded participants with co-
morbid PTSD, as well as all other Axis I and II co-morbid disorders.   
In contrast, Baes et al., (2014) found no difference in the CAR between depression 
groups, with or without a CT history, and healthy controls.  However, the study did not 
include a group with CT only and did not appear to exclude or measure PTSD 
symptomology, which could have been hypothesised to contribute to the difference in 
results.   
Cortisol level summary 
• Overall reduction in cortisol in trauma and clinical groups versus healthy controls 
• Studies differed in whether this reduction was associated with CT or depression 
• Unclear effect of co-morbid PTSD 
• Studies differed in sex of samples and inclusion of co-morbid PTSD 
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All three studies used mixed sex samples but only Lu et al. (2016) conducted an 
analysis by sex and found no effect.  This also contributed to a higher core CCAT score of 
70% for Lu et al. (2016), versus 60% for both Peng et al. (2014) and Baes et al. (2014). 
 
 
 
 
 
 
4.4.2 Reactivity 
Eleven studies looked at HPA axis reactivity and the synthesis was divided by the 
measurement method used (Figure 2).  
a)  Suppression 
Four studies assessed HPA axis feedback regulation using suppression paradigms.  
Different paradigms were used to look at differences in suppression of endogenous cortisol 
release following administration of agonists of GR and/or MR.  There were inconsistencies 
in differences in suppression found between groups.  Co-morbid PTSD and depression 
severity appear to be important factors in accounting for these inconsistencies.  
GR agonist 
Findings of the two studies using the DST, which uses a GR agonist, appeared to 
suggest its effects depended on the presence of co-morbid PTSD.  Groups with depression 
and a CT history but no PTSD indicated reduced suppression, that is a reduction in 
glucocorticoid feedback inhibition when compared to healthy controls, groups with 
depression only, and groups with a CT history only (Lu et al., 2016).  There were no sex 
CAR summary 
• Inconsistent results 
• Two studies found CAR hyperactivity associated with childhood trauma and not 
depression.  Both excluded co-morbid PTSD 
• One study found no difference in CAR between depression groups and healthy 
controls but did not have a childhood trauma only group and handling of co-
morbid PTSD unclear 
 
 
34 
 
effects in the mixed sample.  All female groups with depression and a CT history plus PTSD 
showed an increase in suppression, when compared to the same three groups (Newport et 
al., 2004).  Indeed, the pattern of results stayed the same when PTSD was used as the 
organising diagnosis, rather than depression (Newport et al., 2004), consistent with 
research looking at PTSD and suppression (e.g. Stein et al., 1997).  Where there was a CT 
history but no current depression, there was no evidence of altered negative feedback 
versus healthy controls (Newport et al., 2004).  The Lu et al. (2016) study received a higher 
CCAT core score (70% v 60%) as it used a mixed sample and included sex in the analysis, 
and for its clear exclusion of co-morbid PTSD. 
MR & GR agonists 
The two studies looking at suppression of both MR and GR used different 
paradigms and found contradictory patterns of results.  Baes et al. (2014) investigated MR 
and GR suppression separately by assessing the effect on the CAR after administration of 
dexamethasone (the GR agonist used in the DST), fludrocortisone (a MR agonist) and a 
placebo.  The group with depression and a CT history showed suppression with both GR 
and MR agonists.  Higher CTQ scores and depression severity were associated with 
increased MR malfunction.  Healthy controls and the group with depression only showed 
suppression with the GR agonist only.  This suggested CT was associated with an 
impairment of MR function.  It is worth noting there was no group with a CT history only.  
Levels of co-morbid PTSD in depression samples were also unknown. 
Jurena et al. (2009) used the PST.  Prednisolone is thought to be a MR and GR 
agonist and the PST therefore tests the effect of suppression of both.  The study found no 
difference in suppression between those with depression, with or without a CT history 
(including when separated into emotional, physical and sexual abuse), and healthy 
controls.  This was in contrast with findings from Baes et. al. (2014), and DST studies 
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(Newport et al., 2004; Lu et al., 2016).  Jurena et al. (2009) hypothesised intact negative 
feedback was due to MR compensating for GR impairment.  They also noted tests, such as 
used by Baes et al. (2014), could not purely suppress GR or MR.  Jurena et al. (2009) used 
an inpatient population, assessed as being moderately treatment resistant, who may have 
had more severe depression than other studies using outpatient samples.  The study 
investigated a specific intervention for people with treatment resistant depression.  The 
sample was divided into responders and non-responders to the intervention based on 
changes in depression symptomology.  Non-responders had impaired suppression 
compared to responders and the authors suggested there may be a subgroup within 
depression with impaired suppression and this may affect treatment response.  However, 
differences in CT history between responders and non-responders were not investigated.  
One in nine of Jurena et al.’s (2009) sample with depression had co-morbid PTSD, but no 
separate analysis was undertaken.   
Given the suggested impact of PTSD on findings using a GR agonist alone (Lu et al., 
2016; Newport et al., 2004), the lack of information about, and analysis of, co-morbid PTSD 
within the samples of both Jurena et al. (2009) and Baes et al. (2014) meant this may have 
contributed to the apparently contradictory results.  Both studies received core CCAT 
scores of 60%.  While both studies used mixed samples, neither included sex in their 
analysis.  Neither included a CT only group, again hindering a comparison of results. 
 
 
 
 
 
 
Suppression summary 
• Inconsistent methodologies and results  
• For GR, those with depression, CT and PTSD showed enhanced reactivity, in 
line with PTSD findings.  With no co-morbid PTSD, reduced reactivity was 
found, in line with depression studies  
• For MR, findings differed by whether MR suppression was measured 
separately (impairment found) or with GR (no impairment found) 
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b) Stressors 
There were inconsistent findings in studies using paradigms designed to assess HPA 
axis reactivity to a stressor.  However, different paradigms were used and Suzuki et al., 
(2014) suggested these may be tapping into different levels of the HPA axis.  The Heim 
studies (2000; 2002) used a validated stressor test, the TSST (Kirschbaum et al., 1993).  
Brand et al. (2010) used a specially developed mother/infant paradigm, and Suzuki et al. 
(2014) also used a specially developed paradigm, which included viewing images linked to 
CT as the stressor. 
The two Heim studies (Heim et al., 2000; Heim et al., 2002) used the same data and 
found a CT history was associated with an increase in ACTH (precursor of cortisol), that is 
an enhanced response to a stressor, when compared to healthy controls.  For those with a 
CT history and depression, increases in both cortisol and ACTH were found post-stressor.  
Those with a CT history only showed an enhanced ACTH response to the stressor, but a 
cortisol response similar to healthy controls.  For those with depression only, a normal 
stress response was observed.  Both Brand et al. (2010) and Suzuki et al. (2014) found the 
opposite; a CT history was associated with reduced cortisol post-stressor.  For Suzuki et al. 
(2014), this held whether or not participants had current depression and the depression 
only group showed the highest reactivity.  However, Brand et al. (2010) found depressive 
symptoms, a history of PTSD or current stressful life events moderated the relationship 
between CT history and stress induced cortisol change, all with a small to medium effect 
size.  When plotted against CT history (presence or absence), those with high depressive 
symptoms, a history of PTSD or current stressful life events had higher cortisol levels at the 
different time points than those without a history of trauma.  
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Heim et al. (2002) investigated predictors of maximum cortisol and ACTH using 
data from Heim et al. (2000).  For cortisol and ACTH, a CT history was the strongest positive 
predictor, while number of CT experiences was a negative predictor.  An interaction term of 
CT with trauma in adulthood was the best ACTH predictor but was not a predictor of 
maximum cortisol levels.  For cortisol, but not ACTH, daily life hassles (negatively) and 
depression symptoms (positively) were predictors.  PTSD and current stressful life events 
were not predictors of either maximum ACTH or cortisol levels. 
In all three studies, some participants with depression had co-morbid PTSD.  Brand 
et al. (2010) specifically looked at the effect of PTSD on stress reactivity, while Heim et al. 
(2002) used it as a predictor of maximum levels.   The two studies found contrasting PTSD 
influences.  It is also worth noting that, while the mothers included in the Brand et al. 
(2010) mother and infant dyad study had a history of depression, their current depression 
symptomology was low, and the authors acknowledged a number (not specified) would not 
have met criteria for current depression diagnosis.  While Brand et al. (2010) and the two 
Heim et al. (2000; 2002) studies used female participants, Suzuki et al. (2014) used a mixed 
sample, but did not include sex in the analysis.  The specialist nature of the sample and 
stressor test used contributed to Brand et al. (2010) receiving the lowest quality rating of 
these studies at 55%.  The quality of the other studies was broadly similar (Table 2). 
 
 
 
 
  
Stressors summary 
• Different paradigms used with inconsistent findings  
• Two studies found an enhanced stress response with childhood trauma, with or 
without depression 
• Two studies found a blunted stress response with childhood trauma, but differed 
in the additional influence of depression  
• Inconsistent influence of PTSD, either enhancing stress response or not acting as 
a predictor 
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c) Stimulation 
Heim et al. (2001) looked at the effects of CRF and ACTH stimulation.  In their 
female sample, there were differences between those with a CT history with and without 
depression and between stimulation with CRF and ACTH.  When stimulated with exogenous 
CRF, those with a CT history only showed an enhanced ACTH response compared with 
healthy controls.  Those with depression, either only or in addition to a CT history, showed 
a blunted response.    In terms of cortisol levels following both CRF and ACTH stimulation, 
both groups with CT history showed lower baseline and stimulated cortisol levels, 
compared with healthy controls.   
The group with depression and CT history had significantly higher levels of co-
morbid PTSD (14 out of 15), than CT only (four out of 11).  The depression plus CT group 
also had significantly higher mean negative life events and daily hassles scores than CT 
only, suggesting higher current and chronic stress.  However, no separate analysis was 
conducted, meaning their potential role as confounds is unknown, which contributed to 
the core quality score of 60%.   
 
 
 
 
 
d) Challenge 
Two studies used challenge tests, combining stimulation and suppression tests 
(Heim et al., 2008b and Watson et al., 2007).  While overall the studies found an enhanced 
cortisol response associated with CT, findings differed depending on the addition of 
depression, PTSD and type and level of CT.  Using a male sample, Heim et al., (2008b) found 
Stimulation summary 
• One study only  
• Different responses to stimulation found between those with a CT history with, 
and without, current depression  
• Different responses to stimulation with CRF and ACTH.   
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CT history was associated with enhanced ACTH and cortisol responses to both stimulation 
and suppression.  There were no differences between those with depression only and 
healthy controls, but also no difference between healthy controls and those with CT history 
only.  Only those with a CT history and current depression showed changes in response to 
stimulation and suppression.  When this study used PTSD symptoms as a covariate, the HPA 
axis’s response was reduced.   There was also a positive correlation between cortisol and 
ACTH responses and overall CT scores, sexual and physical abuse subscales, abuse severity, 
CT duration and age of onset. 
The Watson et al., (2007) study compared responses to challenge tests of those 
with depression with a group with bipolar disorder, excluded by most other studies, plus 
healthy controls.  The same enhanced response as in Heim et al. (2008b) was found for the 
clinical sample (i.e. depression and bipolar groups together) with a CT history when 
compared to healthy controls.  However, this was not consistent across the different types 
and levels (high and low) of each CT type.  When compared to healthy controls, the clinical 
group showed an enhanced response on emotional abuse, sexual abuse and physical 
neglect subscales for both high and low trauma groups.  However, the response was only 
higher than the control group for those in the low trauma clinical group on physical abuse 
and emotional neglect subscales.  There was no difference in cortisol responses for those 
with high levels of physical abuse and emotional neglect when compared to healthy 
controls, counter to the original hypotheses.  When high and low levels of the subscales 
were compared, the only significant difference in cortisol response was for emotional 
neglect.  The clinical group was divided by diagnosis for this subscale.  There was no 
difference in cortisol response between those with depression with high and low levels of 
emotional neglect.  For those with bipolar, the cortisol response was lower for those with 
high emotional neglect than low emotional neglect.     
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There were significant methodological limitations to the Watson et al. (2007) study, 
which reduced its usefulness for this analysis, and resulted in it receiving the lowest core 
quality score of 50%.  Co-morbid PTSD did not appear to be formally assessed.  The group 
with depression only had ten participants. The control group data was taken from 
published CTQ data and not a group recruited specifically.  Analysis of the depression group 
(as opposed to total clinical group) was limited, as was sex analysis of the mixed sample.   
 
 
 
 
 
5 DISCUSSION 
Fifteen studies were reviewed to investigate links between depression, a CT history 
and the HPA axis. This section will first summarise the main findings before considering 
evidence relating to potential moderating factors, limitations of the studies, clinical 
implications of findings and making some suggestions for future research.  
 Summary of main findings 
It was difficult to discern from the studies to date whether CT, depression or an 
interaction of the two were associated with changes in HPA axis, the review’s primary aim.  
Comparability was hindered by methodological variation in the studies, a lack of 
replication, and effect sizes only being reported in one study (Brand et al., 2007).  
5.1.1 Reduction in baseline cortisol activity 
Studies reliably showed a reduction in baseline cortisol when compared to healthy 
controls.  However, there were inconsistent findings as to whether this was driven by CT 
Challenge summary 
• Overall enhanced cortisol response with childhood trauma 
• Inconsistent findings in relation to additional influence of depression, PTSD, 
type and level of trauma  
• One study included participants with bipolar disorder in clinical group 
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(Hinkleman et al., 2013, Joyce et al., 2007, Heim et al., 2001) or depression (Lopes et al., 
2010, Brand et al., 2010).  None of the studies found an interaction between CT history and 
depression though, suggesting the effects of the two factors on cortisol levels are 
independent. 
5.1.2 Enhanced reactivity 
There was evidence of enhanced HPA axis reactivity in terms of CAR (Peng et al., 
2014, Lu et al., 2016) and response to: suppression (Newport et al., 2004); a stressor (Heim 
et al., 2000; Heim et al., 2002); stimulation (Heim et al., 2001); and challenge tests (Heim et 
al., 2008b; Watson et al., 2007).  But again, studies differed in terms of whether 
depression, CT or an interaction of the two was driving this enhancement.  For the CAR, 
hyperreactivity was associated with CT, rather than depression (Peng et al., 2014, Lu et al., 
2016).  With suppression and challenge tests, increased suppression was associated with 
the interaction of CT history and depression (Newport et al., 2004; Heim et al., 2008b).  For 
both stressor (Heim et al., 2000; Heim et al., 2002) and stimulation tests (Heim et al., 2001), 
effects differed depending on whether reactivity of ACTH (precursor of cortisol) or cortisol 
was investigated, which suggested the effects on these two products of HPA axis activity 
may be different.   
5.1.3 Blunted reactivity or no difference 
However, there was also evidence of a blunted HPA axis response to: suppression 
(Lu et al., 2016); a stressor (Suzuki et al., 2014 et al; Brand et al., 2010); and stimulation 
(Heim et al., 2001).  Evidence from Lu et al. (2016), Brand et al. (2010) and Heim et al. 
(2001) suggested it was the interaction between depression and CT history that accounted 
for this hyporeactivity of cortisol levels.  For ACTH reactivity to CRF stimulation, results 
were inconsistent, with Suzuki et al. (2014) finding the effect related to CT history alone 
and Heim et al. (2001) to depression, with or without CT.   Furthermore, some studies 
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showed no difference with healthy controls (CAR: Baes et al., 2014; suppression: Jurena et 
al., 2009). 
5.1.4 Differences between depression with and without CT history 
It was also difficult to draw any firm conclusions about whether the HPA axis 
functioning of those with depression and CT history differed from those with depression 
only.  There was some evidence for a difference in: cortisol levels (Hinkleman et al., 2013, 
Joyce et al., 2007); CAR (Peng et al., 2014, Lu et al., 2016); levels of suppression (Lu et al., 
2016; Baes et al., 2014); responses to a stressor (Heim et al., 2000; Suzuki et al., 2014); and 
to challenge tests (Heim et al., 2008b).   But it was not clear whether addition of a CT 
history to a diagnosis of depression was associated with enhanced (Peng et al., 2014; Lu et 
al., 2016; Heim et al 2000; Heim et al., 2002) or blunted (Hinkleman et al., 2013; Joyce et 
al., 2007; Lu et al., 2016; Suzuki et al., 2014) HPA axis functioning.  Furthermore, other 
studies found no difference between these groups for cortisol levels (Lopes et al., 2010; 
Brand et al., 2010), response to suppression (Baes et al., 2014) or stimulation (Heim et al., 
2001).  
 Potential moderating factors 
The review’s secondary aim was to consider potential moderating factors on the 
relationship between CT, depression and HPA axis functioning.  This was hindered by 
heterogeneity in how far study design and sample sizes facilitated an investigation of these 
factors.   
5.2.1 PTSD 
PTSD has been hypothesised to be a moderating factor (de Kloet et al., 2007).  
There was some evidence co-morbid PTSD moderated the effects of depression and CT on 
the functioning of the HPA axis.  Lopes et al. (2010) found a negative correlation between 
PTSD symptomology and cortisol levels, in line with evidence of lower cortisol levels with 
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PTSD (Yehuda, 1998).  For the CAR, if PTSD was excluded, a hyper-reactivity with a CT 
history was found (Peng et al., 2014; Lu et al., 2016).  If it was not, there was no effect 
(Baes et al., 2014). Taken together these results could suggest a moderating effect, given 
evidence for reduced CAR with PTSD (Lemieux & Cole, 1995; Stein et al., 1997).  
Suppression by a GR agonist was increased versus healthy controls when co-morbid PTSD 
was included (Newport et al., 2004), but reduced when it was specifically excluded (Lu et 
al., 2016).  PTSD symptoms reduced the enhanced response to both a stressor (Brand et al., 
2010) and a challenge paradigm (Heim et al., 2008b).  These results accord with findings of 
supersuppression in PTSD, suggesting increased glucocorticoid feedback sensitivity (e.g. 
Stein et al., 1997).   
However, not all studies found an effect of PTSD.  Hinkleman et al. (2013) and 
Brand et al. (2010) found no effect of PTSD on cortisol levels.  PTSD symptoms were not a 
predictor of maximum cortisol or ACTH responses to a stressor test (Heim et al., 2002).    
Additionally, many studies were either unclear about whether or how co-morbid PTSD was 
assessed, or did not specifically include PTSD in their analysis, meaning the influence of 
PTSD on these findings was unknown.  It was therefore, once again, difficult to be anything 
but highly tentative about any conclusions about the influence of PTSD.   
5.2.2 Depression type and severity 
Three studies suggested depression type or severity may also influence the impact 
on HPA axis functioning, and differences in depression severity between studies may help 
to account for inconsistent results.  As depression severity increased: cortisol levels 
decreased (Lopes et al., 2010); MR malfunction increased (Baes et al., 2014); and cortisol 
levels following a stressor did not fall as much (Brand et al., 2010).  However, three other 
studies found no effect of depression severity on cortisol levels (Joyce et al., 2007; Brand et 
al., 2010) nor the CAR (Peng et al., 2014).  The remaining nine did not look at effects of 
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depression severity.   Joyce et al. (2007) did find a small amount of variance in a multiple 
regression predicting cortisol levels was explained by current melancholic symptoms, in line 
with evidence that melancholic depression was associated with a hyperactive, rather than 
hypoactive, HPA axis (Gold & Chrousos, 2002).  Samples also differed in terms of 
depression history.  Interestingly, with a sample of inpatients with severe current 
symptoms, Jurena et al. (2009) found no differences between healthy controls when the 
PST was used as a test of suppression.  Once again, heterogeneity in samples and analyses 
meant it was difficult to draw firm conclusions. 
5.2.3 Type of trauma 
The effects of different types of trauma on functioning of the HPA axis was also not 
clear from the research to date as only five studies investigated these.  For many of the 
others, sample sizes precluded this level of analysis.  While Watson et al. (2007) looked at 
types of trauma, this was for the whole clinical group and therefore included people with 
bipolar disorder as well as (a smaller number) with unipolar depression.  Heim et al. 
(2008b) found a positive correlation between cortisol responses to a CRF challenge test and 
sexual and physical abuse scales.  Jurena et al. (2009) divided the sample by scores on 
emotional, physical and sexual abuse subscales and still found no difference between PST 
responses of healthy controls and those with CT histories.  The impact of CT on the 
functioning of the HPA axis could also be hypothesised to be influenced by severity, 
duration, number of traumatic experiences as well as the age at which abuse started.  Only 
two studies looked at these: Heim et al. (2002) found the number of CT experiences was a 
negative predictor of maximum cortisol and ACTH levels after a stressor; for Heim et al. 
(2008b), severity of abuse, duration and age of onset were positively correlated with 
responses to the challenge tests used. 
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5.2.4 Stress in adulthood 
The rationale for these studies was based on the hypothesis that trauma in 
childhood leads to changes in the HPA axis and its functioning persisting into adulthood.  
Stress and trauma in adulthood also lead to changes in the HPA axis (See Lupien, McEwen, 
Gunnar, & Heim, 2009 for a review).   Therefore, trauma in adulthood, as well as stressful 
life events, has been hypothesised as moderating the relationship, either in addition to, or 
separate from CT (Young and Breslau, 2004).  It may have acted as an additional confound 
in the studies.   
Three specifically included measures of adulthood stress.  Once again, results were 
mixed.  Some found an effect (Brand et al., 2010 found a reduction in cortical response to 
stressors; in Heim et al., 2002, daily life hassles were significant negative predictors of 
maximum cortisol levels following a stressor), and others no effect (Brand et al., 2010 on 
cortisol levels; in Heim et al, 2002, stressful life events were not a significant predictor of 
maximum cortisol levels following a stressor).  While Heim et al. (2001) measured negative 
life events and daily hassles, there was no specific analysis using these variables.  Once 
again, uncertainty around the influence of this potential confound remained.   
5.2.5 Sex 
It has been hypothesised that HPA axis changes resulting from CT may be different 
in males and females (Weiss et al., 1999).  Eight studies in this review used mixed samples, 
six female only, and one male only.  Four of the mixed sample studies included sex in the 
analysis.  None of these found any effect of sex on: cortisol levels (Hinkleman et al., 2013; 
Joyce et al., 2007); CAR (Peng et al., 2004; Lu et al., 2016) and suppression using the DST 
(Lu et al., 2016).  This may have suggested sex was not an important confound.  However, 
the limited number of studies considering sex differences meant this suggestion was 
tentative.  
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 Limitations 
Lack of replication was the main limitation of the studies.  Heterogeneity in sample 
characteristics and methodology greatly hindered comparison, making it difficult to say 
with any confidence what the effects were, and only one study reported effect sizes (Brand 
et al., 2010).  Some of this heterogeneity in methods may be due to the development of 
more effective and accurate ways of measuring HPA axis responsiveness.  For example, 
introduction of the PST meant both MR and GR suppression could be investigated, an 
advantage over the DST, but greatly hindered a comparison with previous studies using the 
DST.  Differences in measures also precluded any form of meta-analysis, which would have 
been useful given the sample sizes of the individual studies. 
Only three studies (Heim et al., 2000; Heim et al., 2002; Heim et al., 2008b) 
included a power analysis.  With the other 12, it was therefore difficult to know whether 
null effects were in fact due to a lack of power.  Sample sizes were small, precluding the 
subanalyses necessary to allow a comprehensive investigation of potential confounds and 
moderators, meaning the influence of these remained unclear.   Nine studies had four 
groups: depression plus CT history, depression only, CT history, healthy controls.  This was 
the most effective structure for looking at group differences but not all studies had this 
structure, which again made it difficult to compare results and effects. 
Studies were also inconsistent in the potential confounding or moderating factors 
included in their analyses.  There are, however, numerous other factors influencing 
functioning of the HPA axis that could be included in future studies.  Joyce et al.’s (2007) 
multiple regression found maternal affectionless control, childhood physical abuse, 
childhood sexual abuse, melancholia and sex only explained 22% of variance in afternoon 
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cortisol levels.  Factors such as family environment at the time of the trauma, attachment 
and other pathology, might be hypothesised to contribute to the other 78%.   
All studies were cross sectional, so it was only possible to look at associations and 
not causality.  There is a great need for longitudinal studies in this area, tracking those who 
have suffered abuse in childhood into adulthood.   
One final limitation was whether a statistically significant difference between 
groups is clinically significant.  For example, while there was a statistically significant 
difference in the CAR between groups, it is not clear whether this would this noticeably 
change an individual’s presentation.  
 Clinical implications 
The lack of confidence about the effects of depression and CT on the HPA axis of 
this review was frustrating from a clinical point of view.  As outlined above, there was a 
tentative suggestion the stress response of the neuroendocrine system of someone with 
depression and CT history may be different to someone with depression without a CT 
history, even if the precise nature of those effects is still unclear.  Heterogeneity in 
treatment response of people with depression, both to medication and talking therapies, is 
well documented (for a review see Nemeroff, 2007).  A CT history may be one factor 
accounting for this heterogeneity and may also suggest a need to include CT history when 
assessing depression.  It could potentially suggest a subtype of depression, emerging as a 
side-effect of chronic trauma reactions following CT and the effect of these on the HPA 
axis.  This subtype of depression may require a different emphasis within interventions, for 
example incorporating elements of self-compassion, which has been found to be effective 
for adults with PTSD reactions to childhood trauma (Lee & James, 2013).  The differences 
found by Jurena et al. (2009) in suppression between responders and non-responders to 
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treatment may also support this idea, although it was not clear how many non-responders 
had a CT history.   
 Suggestions for further research 
There is a clear need for replication using consistent study structures and 
methodologies in this area, especially given the potential clinical implications.  These study 
protocols should facilitate a clear contrast between those with depression and co-morbid 
PTSD, and without co-morbid PTSD.  Depression severity and current life stressors should 
also be routinely measured so their influence can be more thoroughly and consistently 
assessed. It would be optimal for sample sizes of all future studies to be sufficiently large to 
allow an analysis by type of trauma and sex so these too can be more effectively assessed.  
It would also be desirable for effect sizes to be more routinely reported to facilitate a 
comparison of results. 
There is some suggestion the research in this area has moved on, with many now 
looking for epigenetic explanations for changes (for a review see Silberman, Acosta & 
Zubilete, 2016), and also for resilience in those who experience CT but do not develop 
depression.  It is recommended these studies are structured so they can also contribute to 
answering of some of the more fundamental questions around the nature of these 
changes.  
Findings also suggest future studies in other areas using depression groups should 
screen for CT and perform subanalyses on groups with and without CT to explore 
differences in effects between groups.  The differences found between groups with 
depression with and without a CT history may be found in other areas, particularly where 
to date research using a depression group has shown equivocal results. 
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 Conclusion 
This review suggested a CT history and depression were associated with changes in 
the HPA axis, both in terms of basal activity and reactivity.  However, it was difficult to say 
with any certainty what these effects are and whether any effects are driven by a CT 
history, current depression or an interaction between the two.  It was also unclear what 
role sex, co-morbid PTSD, depression severity, current stressors and a whole host of other 
factors played in moderating this relationship.  This was due to heterogeneity in samples 
and methodology and a more general lack of replication. 
These are important questions to answer.  Some of the results could be taken to 
suggest a specific subtype of depression, associated with CT, perhaps with its genesis in 
untreated reactions to the trauma.  This form of depression may be characterised by 
different dysregulation of the HPA axis and therefore reactions to current stressors than 
depression without a history of CT, and may require different treatment approaches. 
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1 ABSTRACT 
Aims: People with depression are biased towards processing emotionally-negative 
stimuli. They also show impairments in hippocampal volume and hippocampus-dependent 
spatial memory.  Here, a cross-sectional design was used to explore, for the first time, 
effects of stimuli affective valence (neutral/negative) on hippocampus-dependent spatial 
memory performance.  
Method: A 2X2 mixed design was used.  Two groups (participants with moderate to 
severe depression; healthy controls) completed the Town Square Test of spatial memory, 
with neutral and negatively valenced stimuli.  Participants’ allocentric memory score 
(correct viewpoint-independent recognition of stimuli’s original location) was used for 
analysis, plus data collected on the depression group’s clinical history and current 
symptomology. 
Results:  Mixed analysis of variance (ANOVA) models were used.  Essentially, no 
effects of valence on allocentric performance were found, for either depression or healthy 
control group.  There were some sex effects: women with depression performed better 
than healthy women in the allocentric shifted view condition, though this was independent 
of valence; and being a female with depression predicted enhanced controlled allocentric 
performance both overall and with negative stimuli, as did increasing age.  Neither current 
symptomology or depression characteristics influenced depression group performance. 
Conclusions:  Potential reasons for the null results were explored, including: 
confounding valence and arousal; lack of valence processing; subjectivity of valence; and 
the depression group’s high levels of co-morbid anxiety.   Further research is required, 
addressing some of these proposed confounds, to elucidate these potentially important 
mechanisms underlying depression.   
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2 INTRODUCTION  
 Depression 
Depression is the most common mental health issue worldwide and an estimated 
one in five of the population will be affected at some point in their lives (Kessler et al., 
2005).  According to the Diagnostic Statistical Manual of Mental Disorders (5th Edition; 
American Psychiatric Association, 2013), to be diagnosed with depression someone must 
have persistent low mood and/or loss of pleasure in activities lasting for at least two weeks, 
plus five additional symptoms from a list including sleep problems, fatigue and 
concentration issues.   
Cognitive models of depression (Beck, 1967) emphasise the role of negative 
schema of the self, the world/others, and the future in the development and maintenance 
of depression.  Explicitly looking to challenge and change these negative schema forms the 
focus of cognitive therapeutic interventions (Beck, 1967, 1976).  While 50%–70% no longer 
meet criteria for depression once cognitive therapy is completed (Craighead, Sheets, 
Brosse, & Ilardi, 2007), at least half of these will relapse within two years (Vittengl, Clark, 
Dunn, & Jarrett, 2007).  Given the significant levels of disability caused by depression (Judd 
et al., 2000), finding out more about processes underlying the disorder is desirable so more 
effective treatments can be developed to improve both recovery and relapse rates. 
 Reductions in hippocampal volume in depression 
Reductions in hippocampal volume in depression are a robust research finding.  A 
recent meta-analysis of fMRI studies found significant reductions in hippocampal volume in 
depression when compared with healthy controls (Schmaal et al., 2015).  This is in line with 
previous meta-analyses (Arnone, McIntosh, Ebmeier, Munafò & Anderson, 2012; 
Lorenzetti, Allen, Fornito & Yücel, 2009; Koolschijn, van Haren, Lensvelt-Mulders, Hulshoff-
Pol & Kahn, 2009; McKinnon, Yucel, Nazarov & MacQueen, 2009).  Within this overall effect 
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on hippocampal volume, Schmaal et al. (2015) found no associations with age, depression 
severity, medication, or co-morbid anxiety.  However, recurrent depression, rather than a 
first episode, was associated with lower volumes versus healthy controls, as was early 
onset before the age of 21.   
Reductions in hippocampal volume have been attributed to atrophy occurring as a 
result of the hypothalamic-pituitary-adrenal axis being chronically hyperactive in 
depression (Campbell & MacQueen, 2004).  This hypercortisolaemia cytoxicity is thought to 
reduce levels of growth-promoting brain-derived neurotrophic factor (BDNF; Cosi, Spoerri, 
Comelli, Guidolin & Skaper, 1993) which in turn suppresses hippocampal neurogenesis 
(Camerson & McKay, 1999).  Evidence from animal studies suggests antidepressant 
medication may in part reduce depression symptoms by increasing BDNF levels, and 
thereby neurogenesis (MacQueen, Ramakrishnan, Ratnasingan, Chen & Young, 2003).  
However, there is only preliminary evidence of this in humans (for a review see Willner, 
Scheel-Krüger & Belzung, 2013). 
 Deficits in autobiographical memory specificity in depression 
There is robust evidence from both lesion (e.g. Scoville & Milner, 1957) and 
neuroimaging studies (see Martinelli, Sperduti & Piolino, 2012, for a review) that one of the 
main functions of the hippocampus is in episodic memory, including autobiographical 
memory for personally experienced events occurring at a particular time and place.   
The presence of overgeneral memory (OGM) in depression is well documented 
(Williams et al., 2007).  OGM refers to difficulties in retrieving specific autobiographical 
memories, coupled with the enhanced recall of categorical memories that also occurs in 
depression (see Williams et al., 2007 for a review).  OGM not only impacts on recall of past 
events, but also imagining the outcomes of future ones (Tulving, 2001), and problem 
solving (Arie, Apter, Orbach, Yefet, & Zalzman, 2008).  It is thought OGM might interfere 
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with cognitive therapy, leaving negative schemas unchallenged, contributing to the 
maintenance of depression. 
Given the robust finding of reduced hippocampal volume in depression, studies 
have looked for an association with OGM.  One group of researchers has consistently found 
increased activity in a hippocampus-centric network when people with depression 
successfully recall specific autobiographical memories.  This is relative to healthy controls 
and when recall is unsuccessful (Young et al., 2013, 2014a, 2014b, 2012).  This network 
includes the pre-frontal cortex, amygdala and hippocampus.  The authors suggest the 
increase in hippocampal activity is necessary to compensate for the reduction in volume in 
depression, allowing specific memories to be successfully retrieved. 
 Deficits in spatial memory in depression 
Another main hippocampal function is in spatial memory.  The hippocampus 
processes the cognitive map, or spatiotemporal context, of autobiographical memories, 
during encoding and recall (O’Keefe & Nadel, 1978).  This allows spatial memory to be 
independent of viewpoint, or allocentric, as opposed to viewpoint dependent or 
egocentric.  While allocentric memory relies on the right hippocampus and medial 
temporal lobe, egocentric memory is dependent on the posterior parietal lobe (Burgess, 
2008; Doeller, Barry & Burgess, 2012). 
Allocentric memory allows for flexible spatial reasoning.  At its most basic, this 
allows objects to be located even when viewpoint changes.  Given the shared 
neurobiological features, the allocentric hippocampal cognitive map has been hypothesised 
to be key in providing a spatio-temporal stamp for autobiographical memories.  These 
allocentric representations allow them to be contextualised and specifically recalled 
(Burgess, Maguire & O'Keefe, 2002) in a coherent order (Tulving, 2002).  This is supported 
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by findings of links between OGM and hippocampal activity in depression (e.g. Young et al., 
2012). 
Recent findings suggest spatial memory may also be impaired in people with 
depression (Cornwell et al., 2010; Gould et al., 2007; Wong, 2015).   Gould et al. (2007) 
used a virtual reality spatial memory test and Cornwell et al. (2010) a virtual version of the 
Morris water maze task.  Both studies found impairments in spatial memory performance 
when compared to healthy controls.   Cornwell et al. (2010) also found a concurrent 
reduction in hippocampal activation while people with depression were completing the 
task.  Both of these tasks, however, require spatial navigation and therefore measure these 
cognitive processes in addition to allocentric performance. 
The Town Square Test (King, Burgess, Hartley, Vargha-Khadem & O’Keefe, 2002) 
measures both allocentric and egocentric memory for object locations.  In a virtual 
environment, participants’ viewpoint is either kept the same between encoding and 
retrieval (testing egocentric memory) or shifted, so recognition takes place from another 
viewpoint (testing allocentric memory).  The Town Square Test is considered to be a more 
precise measure of allocentric spatial memory, both because it does not require navigation-
based processes and because of the instantaneous shift between presentation and test 
viewpoint in the shifted view condition.  This minimises the use of egocentric processes to 
update participants’ location during the move from presentation to test viewpoint (Burgess 
et al., 2002).  As the shifted view condition may also use egocentric processes, participants’ 
score in the egocentric same view condition can be subtracted from their score in the 
shifted viewpoint condition to give an indication of allocentric memory performance 
controlling for egocentric performance.   
The Town Square Test has been structured so same and shifted view conditions are 
difficulty matched for healthy controls.  There should, therefore, be no difference in 
performance between these conditions.  Studies using the Test have broadly supported 
69 
 
this, although one study found deficits in allocentric performance for control group 
participants (Wilkins et al., 2013). 
Participants with hippocampal lesions only show deficits in shifted viewpoint 
performance (King et al., 2002).  These findings support both the hippocampus’ role in 
allocentric spatial memory and use of the Town Square Test to assess hippocampal 
functioning.  Using the test, Wong (2015) found allocentric memory deficits in depression, 
both relative to egocentric memory and healthy controls (using data from Smith, Burgess, 
Brewin & King, 2015), suggesting hippocampal functioning impairment, in line with reduced 
hippocampal volume (Schmaal et al., 2015). 
 Mood congruence in depression 
2.5.1 Recognition memory 
The general population shows enhanced recognition memory for positive stimuli 
versus neutral and negative stimuli (Dolcos, LaBar, & Cabeza, 2004).  For people with 
depression, the opposite pattern is seen and recognition performance is only enhanced 
with negatively-valenced stimuli (Roberson-Nay et al., 2006).  This difference is thought to 
be due to preferential encoding of mood congruent stimuli (Bower, 1981). 
2.5.2 OGM 
There is consistent evidence of mood congruence effects in OGM (see Williams et 
al., 2007 for a review).  While people with depression show impaired autobiographical 
memory specificity overall compared to healthy controls, they are better able to produce 
specific memories to negative cue words than positive ones.  The pattern is reversed for 
healthy controls (Williams & Scott, 1988).   
2.5.3 Emotional attention and cognitive control 
Mood congruent biases towards negative stimuli in depression have also been 
found in terms of attention (Mathews, Ridgeway & Williamson, 1996), with an enhanced 
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perigenual anterior cingulate cortex (pACC) response implicated (Mitterschiffthaler et al., 
2003).  People with depression also exhibit poorer cognitive control (see Castaneda et al., 
2008 for a review), and are less able to suppress responses to negatively valenced stimuli 
where these are irrelevant, affecting task performance (e.g. Joorman & Gottlib, 2008).  
 Accounting for mood congruence effects 
Two hypotheses account for when and how mood congruent stimuli may affect 
task performance of both healthy controls and people with depression.   
2.6.1 Modulation hypothesis 
According to the modulation hypothesis, encoding and consolidation of affective 
information within the medial temporal lobe (MTL), including the hippocampus, is 
modulated by the amygdala (McGaugh, 2002).  It is suggested this enhanced amygdala-MTL 
interaction accounts for enhanced memory for affective stimuli (Dolcos et al., 2004).   
For people with depression, it has been hypothesised the mood congruence effect 
on memory results from a lowering of the threshold for engagement of the amygdala in 
memory formation with negative stimuli.  This overactivation of the neural pathway of the 
modulation hypothesis means the amygdala is more readily engaged than in people 
without depression (Roberson-Nay et al., 2006).  Thus, while reduced memory for neutral 
and positive stimuli in depression is thought to result from reduced hippocampal volume, 
enhanced memory for negative stimuli is linked to enhanced connectivity between the 
amygdala and hippocampus.  Supporting this, Hamilton and Gotlib (2008) found greater 
interaction between the amygdala and hippocampus in a depression group than a non-
depressed group only during successful encoding of negative stimuli in a recognition 
memory task.  Additional support comes from neuroimaging evidence that both the 
hippocampus and amygdala are overactivated by negative stimuli in depression (e.g. Fu et 
al., 2004), as is the pACC, connecting the two (see meta-analysis by Sacher et al., 2012).  
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Given the involvement of the hippocampus in OGM, modulation could account for OGM 
mood congruence effects in depression. 
2.6.2 Affective Interference Hypothesis 
There is also evidence that negatively valenced stimuli act as a distractor for people 
with depression when valence is irrelevant, disrupting task performance (Siegle, 
Steinhauer, Thase, Stenger & Carter, 2002; Joorman & Gottlib, 2008, 2010).  According to 
the Affective Interference Hypothesis (Gottlib & Joorman, 2010), people with depression 
process emotional material first, even when task-irrelevant.  This is the result of a 
combination of preferential emotional attention, leading to difficulties disengaging 
attention from negative stimuli (Wang et al., 2008), and deficits in cognitive control, making 
it difficult to suppress the response to valence when this is task irrelevant (Clark, 
Chamberlain, & Sahakian, 2009).  This cognitive control failure has been linked to deficits in 
the dorsal anterior cingulate cortex (Posner & Rothbart, 2007) and the prefrontal cortex 
(e.g. Bench, Friston, Brown, Frackowiak & Dowan, 1993).  In summary, if stimuli valence is 
mood congruent but task-irrelevant, it may interfere with task performance, rather than 
enhance it (Gottlib & Joorman, 2010). 
 Mood congruence and spatial memory 
There is tentative support for affective interference in a spatial memory task.  
When asked to recall the location of a valenced picture after a delay, scores reduced as 
affective arousal of the images increased (Mather et al., 2006).  While this study did not use 
a depression group, depression symptomology was measured.  As depression scores 
increased, spatial memory for negative pictures decreased.  The authors suggested this 
interference was due to an impairment in feature binding.  In line with the affective 
interference hypothesis, emotional components were processed preferentially to the 
detriment of feature binding in working memory required to remember location.  The 
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authors referred to this as ‘mental rubbernecking’, whereby mood congruent valence 
means the item is remembered, but not its location. 
However, the study did not involve a viewpoint shift.  It therefore measured 
egocentric spatial memory, using the posterior parietal lobe and not hippocampally-
dependent allocentric memory.  It is therefore not known whether affective interference 
still occurs when the hippocampus is involved and modulation may occur.  
 Rationale and aims of study  
2.8.1 Rationale 
While the reduction in hippocampal volume is a robust finding in depression 
(Schmaal et al., 2015), implications for day to day functioning of people with depression are 
less clear cut.  It can lead to impairments in hippocampally-dependent memory (Williams et 
al., 2007; Wong, 2015), but there is also evidence of compensatory increases in 
hippocampal activity in some instances (e.g. Young, 2012).  
Adding further complexity is the influence on performance of stimuli’s emotional 
content in depression and what this might tell us about how processing valence influences 
hippocampal functioning, including connectivity with the amygdala.  This area has not 
received much attention to date. 
 This study therefore looked to pull together these strands of research into memory 
processes and mood congruence effects in depression by investigating for the first time the 
impact of valenced stimuli on hippocampally-dependent allocentric memory.  As 
neurobiological evidence suggests the same medial temporal structures are involved in 
both of these processes, establishing a link in terms of observable memory performance 
would be informative of mechanisms underlying these features of depression.  For the non-
depressed control group, this was also the first investigation of the effect of valenced 
stimuli on allocentric spatial memory.   
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The study built on the previous investigation of allocentric memory in depression 
(Wong, 2015) by using valenced stimuli in the Town Square Test.  In Wong’s (2015) study, 
and all previous research using the Town Square Test, stimuli were low resolution images.  
Stimulus valence had not been explicitly controlled, although there had been an 
assumption stimuli were not strongly valenced, positively or negatively.  Here, both neutral 
and negatively valenced stimuli were used to allow effects on performance to be 
investigated.  Words were used rather than images to allow valence to be more reliably 
manipulated, by using a normed database (Warriner, Kuperman & Brysbaert, 2013).   
2.8.2 Primary aim and hypotheses 
The primary aim of the research was therefore to investigate effects on allocentric 
memory performance of stimulus type (neutral or negative) and any differences between 
people with depression and healthy controls.   In Wong’s (2015) study, when (uncontrolled) 
neutral stimuli were used, people with depression showed impairments in allocentric 
performance, both in relation to healthy controls and egocentric performance.  This 
research extended this by comparing this with performance when negative stimuli were 
used.    
This was the first time the interaction between allocentric memory and the valence 
of stimuli had been studied.  Modulation and affective interference hypotheses would 
make different predictions for the impact on performance of using negatively valenced 
stimuli.  These alternative hypotheses were explored.  For neutral stimuli, there was a 
single hypothesis as both modulation and affective interference hypotheses would make 
the same predictions. 
Neutral stimuli 
Hypothesis: The depression group will show the same impairment in the shifted 
view condition when compared to the same view condition as found in Wong’s (2015) 
study.  The control group will not show an impairment.  The controlled allocentric memory 
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performance (i.e. when same view scores are subtracted from shifted view scores to 
control for egocentric memory performance) of people with depression will also be 
significantly worse with neutral stimuli than healthy controls’.  This will be due to 
hippocampal impairment (Schmaal et al., 2015). 
Negative stimuli 
Enhancement hypothesis: Shifted view performance will be significantly better for 
people with depression, both when compared to their own same view performance, and 
healthy controls’ shifted view performance.  Controlled allocentric memory performance 
with negative stimuli will also be significantly better for people with depression than 
healthy controls and performance with neutrally valenced stimuli.  This will be due to 
enhanced connectivity between the amygdala and hippocampus improving performance 
with negatively valenced stimuli in the hippocampally-dependent allocentric condition for 
people with depression.  
Interference hypothesis: In the Town Square Test, valence is irrelevant to the task.   
For people with depression, processing negatively valenced words will interfere with 
processing location and therefore test performance.  Given the enhanced cognitive 
demands of the shifted view condition, interference will be greater in this condition than 
the same view condition, and for controlled allocentric performance.  For the control 
group, interference will not occur and performance will be better than the depression 
group with negative stimuli on same and shifted view conditions and for controlled 
allocentric performance.   
2.8.3 Secondary aim 
The secondary aim was to explore predictors of allocentric performance with 
negative stimuli in depression.  According to the meta-analysis (Schmaal et al., 2015), early 
onset of depression (before the age of 21) and number of episodes are predictive of 
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hippocampal volume reductions, and so tentatively might be hypothesised to influence 
allocentric performance with negatively valenced stimuli.  Similarly, this meta-analysis also 
found no association between hippocampal volume, symptom severity and co-occurring 
anxiety, and so, again tentatively, these may be hypothesised to not influence 
performance. 
 
3 METHOD 
 Joint project arrangement 
This was a joint project with another trainee clinical psychologist (Sagfors, 2017; 
see Appendix A).  Data collection was shared as both projects used the same participants 
and there was overlap in measures.  However, the other trainee’s research question 
focused on links between OGM and allocentric spatial memory as an indicator of 
hippocampal function.  Therefore, different primary variables were used for analysis.  Only 
data for this project have been included here. 
 Research design 
This cross-sectional study used mixed designs to investigate the primary research 
aim.  For all designs, the between groups independent variable was group (two levels: 
depression; control) and the within group independent variable was stimulus valence (two 
levels: neutral; negative).  A 2x2x2 mixed design added viewpoint (two levels: same; 
shifted) as a within group variable and used correct location recognition as the dependent 
variable.  A 2x2 mixed design used controlled allocentric memory score (shifted view minus 
same view percentage correct) as the dependent variable to investigate any effects of 
stimuli valence for the two groups. 
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Multiple regression was used to explore predictors of controlled allocentric memory 
performance with negative stimuli for the depression group, which formed the secondary 
research aim. 
 Sample size: power analysis 
This was the first time valenced stimuli had been used within the Town Square 
Test.  Wong (2015) found a large effect size (.83) for differences in allocentric memory 
between a depression group and data for healthy controls from another study (Smith et al., 
2015).  A previous study using the Test (Smith et al., 2015), found a medium effect size 
(partial eta-sq. = .1) for the relationship between allocentric memory performance and 
posttraumatic stress disorder.  Similarly, using the Test to investigate the relationship 
between performance and experience of induced trauma memories for a healthy sample, 
Bisby, King, Brewin, Burgess & Curran (2010), found a medium to large effect size for the 
negative relationship (r=-.43).   
A power analysis conducted for the joint project using GPower 3.1 (Faul, Erdfelder, 
Lang, & Buchner, 2007), with a power level of .80 and alpha of .05, suggested a sample size 
of 68 (34 in each group) to detect a small to medium effect.  A subsequent sensitivity 
analysis used GPower 3.1 (Faul et al., 2007) for a repeated measures ANOVA (within-
between interaction) with two groups and two measures, assuming sphericity and 
correlation between measures of .50.  With a sample size of 68, at the same power and 
alpha levels, an effect size of at least .17 (small to medium) would be detectable.   
 Setting 
Recruitment and testing of the depression group was based within an NHS 
Improving Access to Psychological Therapies (IAPT) service.  Control group participants 
were recruited through two routes (see Figure 1) and testing took place at UCL’s 
Department of Psychology. 
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 Participants 
A total of 72 participants were recruited, 35 for the control group and 37 for the 
depression group.  All participants were 18-65 years old.  Inclusion and exclusion criteria for 
both groups were designed to reduce the potential impact of confounding variables on 
spatial memory performance, including key co-morbid and neurological disorders (see 
Figure 1).  For the depression group, onset at least 2.5 years ago was an inclusion criterion 
as this had been found to be associated with hippocampal damage (Schmaal et al. (2015).   
Co-morbid anxiety was allowed for the depression group as Schmaal et al.’s (2015) meta-
analysis found no association between hippocampal volume and co-occurring anxiety, and 
as the two disorders commonly co-occur (Moffitt et al., 2007).   
Participants who were UCL undergraduates were incentivised through credits 
towards a compulsory course requirement.  All other participants were paid £12.50 at the 
end of participation as compensation for travel expenses.   
 Ethical considerations 
Wong’s (2015) study recruited from the same IAPT service and was granted ethical 
approval by the National Research Ethics Service (NRES) Committee East Midlands – 
Nottingham 2 in August 2014 (REC reference: 14/EM/0222).  An amendment to this ethics 
for this project was obtained (see Appendix B for letter granting approval), as recruitment 
was from the same sites and cohort.  The control group was recruited and tested under the 
project supervisor’s existing UCL CEHP programme ethics approval (SHaPS-2014-JK-009). 
In terms of managing risk, all testing for the depression group took place on IAPT 
sites and any concerns around risk were raised with the duty worker.  There was one 
incident, managed in line with this protocol.  For the control group, researchers assessed 
risk on an individual basis, deciding whether confidentiality needed to be broken (e.g. 
where potential for harm was high).  There were no incidences. 
 
 
 
Figure 1: Summary of procedure phases and routes, eligibility criteria and measures used in each phase for depression and control groups 
 
 
 Procedure 
See Figure 1 for a summary. 
3.7.1 Phase one: Recruitment of potential participants 
Depression group  
The depression group was identified using two routes.  Firstly, IAPT clinicians made 
referrals for screening based on inclusion and exclusion criteria, obtaining verbal consent 
for their clients to be contacted by study researchers by telephone. Two clinician referrals 
were received.  
Secondly, researchers were provided with a list of the IAPT service’s clients who 
had consented to being contacted for research purposes.  Participants were e-mailed to 
assess willingness to participate if they met the following criteria: aged 18-65; scored ten or 
more on their latest Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 
2001); were currently being seen by the service (i.e. not discharged); were low risk.  Follow-
up calls were made within a week.  A total of 282 potential participants were contacted 
using this route. 
Control group  
Participants were recruited through two online facilities: UCL Psychology Subject 
Pool; and www.callforparticipants.com.  Sites included information on the main inclusion 
and exclusion criteria.  Potential participants signed up for telephone screening and testing 
slots.   
3.7.2 Phase two: telephone screening 
All participants were screened by telephone to ensure they met inclusion and 
exclusion criteria (Figure 1 summarises criteria and measures for each group).  
Standardised measures, including the PHQ-9 (Kroenke et al., 2001), Generalised Anxiety 
Disorder-7 (GAD-7; Spitzer, Kroenke, Williams, & Löwe, 2006) and a subset of the Structure 
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Clinical Interview for DSM Disorders (SCID-I; First, Spitzer, Gibbon & Williams, 2002), were 
supplemented with specific questions.  If participants did not meet criteria, they were told 
they were ineligible to participate and contact was terminated. 
In the depression group, out of 60 people screened, 21 were ineligible.  In the 
control group, of the 39 screened, two were ineligible. 
3.7.3 Phase three: Testing of eligible participants 
Eligible participants were given a testing appointment and e-mailed the relevant 
participant information sheet in advance.  Written consent was obtained at the start of the 
testing session (see Appendix C). Relevant additional measures for each group were then 
administered (see Figure 1), followed by joint project measures.  Participants then 
completed the Town Square Test before finally completing a questionnaire rating the 
valence of the words used in the Test.  Participants were paid or given course credit as 
appropriate on completion.  Thirty-six depression group and 35 control group participants 
completed testing. 
 Measures 
Figure 1 summarises measures used during Phase two telephone screening.   
3.8.1 Phase three: testing of eligible participants 
Allocentric memory measure: Town Square Test (King et al., 2002) 
For the Town Square Test, a virtual environment consisting of a courtyard with 
distinct buildings around the perimeter was observed on a laptop with a 15-inch screen.  In 
the presentation phase, participants were shown stimuli in blocks of six, one at a time for 
three seconds each in one of 21 randomly located placeholders on the courtyard floor, with 
an interval of one second between presentation items.  In the test phase, participants were 
shown each stimulus in its original location placeholder along with three identical foils in 
random placeholders.  Each of the test stimuli was coded with a coloured square, and 
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participants used this to indicate the correct presentation location.  There was no time 
limit. Presentation order within a block in the test phase was randomised to reduce 
predictability and use of mnemonic strategies. 
Two viewpoints in opposite corners of the courtyard were used for presentation 
and test (Figure 2).  There were two viewpoint conditions. In the same-view condition, 
viewpoint remained the same between presentation and test (Figure 2, a) and b)).  In the 
shifted-view condition, presentation was at one viewpoint and test at the other, that is 
viewpoint shifted between presentation and test (Figure 2 c) and d)).   The viewing rotation 
required to move from one view to the other was 140 degrees.    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Town Square Test.  Views overlooking the middle of the virtual environment 
courtyard.  The same viewpoint condition is shown in a) (presentation) and b) (testing).  The 
shifted viewpoint condition is shown in c) (presentation) and d) (testing), with the traffic 
cone in d) showing the point from which stimuli were viewed at presentation in c).   
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Same and shifted view conditions have been difficulty matched to reduce 
performance differences for control participants (King, Trinkler, Hartley, Vargha-Khadem, & 
Burgess. 2004).  Foil locations were nearer the target in the same view condition to make it 
more difficult, and foil locations were spread across the courtyard for the shifted view 
condition to facilitate correct responses. 
Previous versions of the Town Square test had used low resolution photographs of 
objects as stimuli (King et al., 2002).  Images were chosen for their recognisability and 
valence was not specifically controlled.  Stimuli valence may therefore have acted as a 
confound.  To control stimulus valence in a reliable way, a word-based version was 
developed specifically for this project. 
Neutral and negatively valenced words were taken from a database (Warriner et 
al., 2013) which provides valence norms for 13,915 English lemmas.  Norms were based on 
responses of 1827 participants who rated their first and immediate affective reactions to 
words on a scale from one to nine, with one indicating feeling completely unhappy, nine 
completely happy and five if neutral about the word.   
For this study, neutral words were selected from those scoring 5 +/- .08 (e.g. barrel, 
jigsaw).  For negative words, lowest scoring words were selected (e.g. poison, traitor). To 
minimise distress or disturbance, no words were selected relating to: violence, weapons, 
sex, disease or words generally considered to be taboo.  These words also showed 
significant differences in database ratings between males and females (Warriner et al., 
2013).   
A homogenous set was selected, controlled for word length (5-7 letters) and 
reading scores.  Appendix D contains the words used with their valence ratings.  For 
negative words, the range of valence ratings was 1.88 (pollute) to 2.52 (creepy), mean was 
2.22 and standard deviation .19.  For neutral words, the range was 4.92 (barrel) to 5.05 
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(various, e.g. canteen), mean was 5.00 and standard deviation .04.  Words were presented 
in a black typeface on white background.  Arial, a sans serif font, was chosen for maximum 
legibility at variable size as words were scaled with distance (Figure 2).   
There was evidence the enhanced memory effect for negatively valenced stimuli 
with depression persisted after stimulus presentation (Siegle et al., 2002).  To address this, 
neutral and negative words were presented in separate blocks with order of presentation 
randomised across participants. There were eight blocks of six for each valence condition, 
four blocks for each viewpoint condition.  A total of 96 words was presented, 24 in each of 
the four combinations of viewpoint (same, shifted) and valence (neutral, negative).   
Processing the words including their valence was not necessary to complete the 
task.  Therefore, participants were told prior to starting they would be asked at the end for 
their affective reaction to the words and to bear this in mind when completing the task (see 
Appendix E).   
For the analysis, a percentage correct score for same and shifted viewpoints for 
both the neutral and negatively valenced word conditions was calculated.  A measure of 
allocentric performance, controlling for differences in egocentric performance was 
calculated as the difference between shifted (using allocentric and egocentric processes) 
and same view performance (using egocentric only). 
Additional measures 
For the depression group, the Beck Depression Inventory (BDI-II; Beck, Steer, Ball & 
Ranieri, 1996) was used to indicate depression severity, and the GAD-7 to assess presence 
and levels of co-morbid generalised anxiety disorder (GAD).  Clinical information was 
collected using a bespoke questionnaire (see Appendix F).  
For the control group, the Ten Item Personality Measure (TIPI; Gosling, Rentfrow & 
Swann, 2003) was administered to assess neuroticism as research had suggested 
neuroticism was a risk factor for depression (Kendler, Gardner, & Prescott, 2002; Kendler, 
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Kessler, Neale, Heath & Eaves, 1993).  Individuals with high neuroticism had also been 
found to show similar memory biases towards negative stimuli as people with depression 
(Ruiz-Caballero & Bermudez, 1995).  A neuroticism score was derived by summing the two 
neuroticism items. 
For both groups, demographic information was collected using a bespoke 
questionnaire (see Appendix G), including age, sex, ethnicity and whether English was the 
participant’s first language.   
Joint project measures 
Two measures were also administered specifically for the joint project: Four 
Mountains Test (Hartley et al., 2007); and Autobiographical Memory Test (Williams & 
Broadbent, 1986). 
 Data analysis procedures 
To analyse the primary research question, firstly, a 2 (group: control; depression) 
x2 (valence: neutral; negative) x2 (viewpoint: same; shifted) mixed model mixed analysis of 
variance (ANOVA) was used with total percentage correct as the dependent variable.  
Because hippocampus-dependent memory performance reduces with age (Raz et al., 
2010), age was controlled for by adding as a covariate.  Sex was also added to this model as 
there is evidence of sex differences in spatial memory (Grön, Wunderlich, Spitzer, Tomczak 
& Riepe, 2000).  To investigate any order effects, presentation order of valenced stimuli 
was also added. 
A 2 (group: control; depression) x 2 (valence: neutral; negative) ANOVA was then 
used with controlled allocentric performance score (shifted minus same scores) as the 
dependent variable.  Once again, age was a covariate, and sex and order were added to the 
model.   
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To explore predictors of performance for the depression group, hierarchical 
multiple regression was used.  Block 1 contained potential demographic confounds, Block 2 
symptomology variables and Block 3 depression characteristic variables. 
 
4 RESULTS 
 Data preparation and exploration 
Data analysis was performed using the Statistical Package for Social Sciences 
Version 24 (SPSS, IBM Corp. in Armonk, NY).  Dependent variables were first investigated 
for outliers and adherence to assumptions of parametric tests. 
Normality checks: the z-scores for kurtosis and skewness were calculated for each 
of the Town Square Test variables for both groups.  None of the values were more than 
z=2.5 or p=.01.  In addition, none of the Kolmogorov-Smirnov tests were significant at a 
threshold of p<.01.  The distributions of the dependent variables for both groups were 
therefore assumed to meet assumptions of parametric testing. 
Outliers: standardised z scores were calculated for the Town Square Test variables. 
A threshold of +/- 3 was applied.  No outliers were identified in either control or depression 
group. 
 Participant demographics and clinical characteristics 
Three depression group participants were excluded from the analysis; two because 
they did not complete the Town Square Test and one because they were left handed.  The 
demographics of participants included in the analysis are detailed in Table 1.  There were 
no differences between groups in terms of demographics (see Table 1 for test statistics).  A 
Chi-squared test for ethnicity could not be conducted as it was not possible to combine 
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categories in a meaningful way to achieve cell sizes of more than five.  Asian was the 
biggest ethnic group for the control group; White British for the depression group.   
 
Table 1 
Demographic characteristics of participants by group plus test statistics for group 
differences 
 Control group 
N=35 
Depression group 
N=34 
Test statistic and p 
value 
Age (years) M (SD, range) 
 
31.66 (11.40, 
18-62) 
34.76 (12.72, 20-
59) 
t(66)=1.02, p=.31 
Gender N (%) 
Male 
Female 
 
 
13 (37) 
22 (63) 
 
17 (51.5) 
16 (48.5) 
 
2 (1)=1.16, p=.28 
Ethnicity N (%) 
White British 
White Other 
Black/Black British 
Asian 
Asian British 
Mixed 
Other 
 
 
6 (17.1) 
8 (22.9) 
5 (14.3) 
12 (34.3) 
0 (0) 
3 (8.6) 
1 (2.9) 
 
 
18 (54.5) 
8 (24.2) 
2 (6.1) 
2 (6.1) 
3 (9.1) 
2 (6.1) 
0 (0) 
 
 
N/A 
English as a first language N (%) 
Yes 
No 
 
22 (62.9) 
13 (27.1) 
 
 
26 (78.8) 
7 (21.2) 
 
2 (1)=2.30, p=.13 
Employment status N (%) 
Employed 
Unemployed/student 
 
 
16 (45.7) 
19 (54.3) 
 
20 (60.6) 
13 (39.4) 
 
2 (1)=1.78, p=.18 
Education N (%) 
Up to undergraduate 
Undergraduate 
Postgraduate 
 
 
9 (25.7) 
11 (31.4) 
15 (42.9) 
 
9 (27.3) 
13 (39.4) 
11 (33.3) 
 
2 (2)=5.07, p=.08 
Income N(%) 
Up to £25,000 
£26,000 - £50,000 
Over £50,000 
 
 
16 (45.7) 
17 (48.6) 
2 (5.7) 
 
13 (39.4) 
10 (30.3) 
8 (24.2) 
 
2 (2)=5.07, p=.08 
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The depression group’s clinical characteristics are summarised in Table 2.  For BDI-
II, categorises of minimal (0-9), mild (10-18), moderate (19-29) and severe (30-63) were 
used (Beck, Steer & Garbin, 1988).  For GAD-7, categories of minimal (0-4), mild (5-9), 
moderate (10-14) and severe (>15) were used (Spitzer et al., 2006), as well as numbers 
meeting a diagnostic threshold for generalised anxiety disorder (score of ten or more; 
Spitzer et al., 2006).  Participants were categorised as having either a first degree relative 
with a history of depression (parents, siblings), only a second degree relative (grandparent, 
aunt, uncle, nephew, niece or cousin), or none.   
Table 2 
Clinical characteristics of the depression group 
 
  
 Depression group 
N=34 
BDI 
Score M (SD, range) 
Category N (%) 
    Mild 
    Moderate 
    Severe 
 
 
29.18 (8.11, 11-48) 
 
2 (6.1) 
14 (42.4) 
17 (51.5) 
 
GAD-7 
Score 
Category 
    Minimal 
    Mild 
    Moderate 
    Severe 
 
Cut-off 
 
 
11.15 (3.51, 4-21) 
 
1 (3.0) 
11 (33.3) 
16 (48.5) 
5 (15.2) 
 
29 (87.9) 
Depression history  
Years since first episode M (SD, range) 
Start of current episode (months) M (SD, range) 
Length of current episode (months) M (SD, range) 
Total number of episodes M (SD, range) 
Currently taking medication N (%) 
Currently undergoing talking therapy N (%) 
Number of sessions of talking therapy to date M (SD, range) 
Family history N (%) 
     First degree relative 
     Second degree relative 
     None 
 
 
17.18 (12.15, 3-50) 
25.15 (38.14, 3-216) 
25.21 (37.51, 3-216) 
3.92 (1,44, 1-7) 
18 (54.5) 
29 (87.9) 
5.38 (4.08, 0-20) 
 
23 (69.7) 
3 (9.1) 
6 (18.2) 
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 Comparison of shifted and same viewpoint conditions 
Figure 3 shows mean percentage total correct for each group by valence in same and 
shifted viewpoint conditions.   
 
 
 
 
 
 
 
 
Figure 3. Mean percentage total correct for each group by valence in same and shifted 
viewpoint conditions.  Error bars represent 95% CI for mean. 
Controlling for age (M=33.16), a 2x2x2 mixed model ANOVA with group (control, 
depression) as between subjects factor and viewpoint (same, shifted) and valence (neutral, 
negative) as within subjects factors showed a main effect of viewpoint (F(1.65)=6.15, p=.02, 
ηp2= .09).  There were no significant main effects for valence (F(1,65)=2.05, p=.16, ηp2=.03) 
or for group (F(1,65)=.33, p=.57, ηp2=.01).  The interactions between view and group 
(F(1,65)=2.80, p=.09, ηp2=.04), valence and group (F(1,65)=.13, p=.72, ηp2=.01), view and 
valence (F(1,65)=1.78, p=.30, ηp2=.02), and valence, view and group (F(1,65)=.68, p=.42, 
ηp2=.01) were all non-significant.  If valence and group were ignored, participants did 
significantly better in the same view condition (EMM = 63.87) than the shifted view 
condition (EMM = 57.35).  No post-hoc analysis was therefore conducted.   
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As the view by group interaction was approaching significance, the interaction plot 
was inspected (Figure 4).  This suggested a trend towards people with depression 
performing better than the control group in the shifted view condition.   
 
 
 
 
 
 
 
 
Figure 4. Mean percentage total correct for each group in same and shifted viewpoint 
conditions. Error bars represent 95% CI for mean. 
 
4.3.1 Sex 
As a way of investigating potential reasons for the trend above and given reported 
differences in terms of sex for spatial memory performance, sex was added to the model as 
a between subjects factor.  There was a significant interaction between group, viewpoint 
and sex (F(1,63)=5.12, p=.03, ηp2=.08).  Inspection of the plots suggested this was driven by 
women with depression performing better in the shifted view condition than men with 
depression and male or female healthy controls (See Figure 5).    
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Figure 5. Mean percentage correct for each group by sex in same and shifted viewpoint 
conditions.  Error bars represent 95% CI for mean. 
 
A post-hoc analysis was therefore conducted for female participants only (control: 
N=22; depression: N=16).  Overall shifted and same view performance was calculated as an 
average across valence factors.  Initially, a 2 (between; group: control; depression) x 2 
(within; viewpoint: same; shifted) mixed ANOVA with age as a covariate was conducted.   
There was no main effect of viewpoint (F(1,35)=.65, p=.43, ηp2=.02) or group (F(1,35)=1.41, 
p=.24, ηp2=.04) but there was an interaction between viewpoint and group, as might have 
been expected from the plots (F(1,35)=9.65, p=.004, ηp2=.22).  A between groups 2 (group: 
control; depression) x 2 (viewpoint: same; shifted) ANOVA with age as a covariate was then 
used to investigate this interaction.   There was a main effect of group (F(2,34)=5.02, p=.01, 
ηp2=.23).  Analysis of simple effects revealed no viewpoint simple effect in the same view 
condition (F(1.35)=.26, p=.62, ηp2=.01), that is no difference in performance between 
women with depression (M=60.54; SD=16.90) and in the control group (M=65.34, 
SD=10.30) when viewpoint was kept the same between presentation and test.  However, 
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women with depression (M=62.24, SD=15.64) performed significantly better when 
viewpoint was shifted between presentation and test than healthy control females 
(M=54.92; SD=13.62; F(1.35)=5.92, p=.02, ηp2=.15).   
4.3.2 Order 
To test for any effect of the order in which valenced stimuli were presented, order 
was added to the model (with age as a covariate but removing sex).  There was no main 
effect of order (F(1,63)=.06, p=.82, ηp2=.001).  However, there was a significant interaction 
between valence and order (F(1,63)=4.21, p=.04, ηp2=.06).  In other words, if group and 
viewpoint were ignored, performance with neutral and negative stimuli were significantly 
different depending on which stimuli were presented first (Figure 6).   
To test this interaction, overall performance with neutral and negative stimuli was 
calculated by averaging performance across viewpoint conditions.  These figures were then 
adjusted for age.  When neutral stimuli were presented first, a paired t-test showed no 
difference in overall performance with neutral stimuli (M=59.44, SD=15.51) and negative 
stimuli (M=59.80, SD=14.70; t(33)=.21, p=.83; 95%CI [-3.87-3.13]).  When negative stimuli 
were presented first, there was a significant difference; participants performed better 
overall with neutral (M=64.27, SD=16.47) than negative stimuli (M=58.82, SD=12.25; 
t(33)=2.70, p=.01; 95%CI [1.34-9.57]).  
Concerns about power meant no additional demographic and clinical variables were 
added to the model. 
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Figure 6. Mean percentage correct for valence condition by order of stimuli presentation.  
Error bars represent 95% CI for mean. 
 
 Controlled allocentric memory performance 
The shifted-view minus same-view percentage correct score was used to give an 
indication of allocentric memory performance, controlling for egocentric memory 
performance.  Figure 7 shows mean controlled allocentric performance by group and 
valence.  This was used as the dependent variable in a mixed 2 (group: depression, control) 
x2 (valence: neutral, negative) mixed model ANOVA, once again controlling for age.  The 
ANOVA did not show a main effect of group (F(1,65)=2.80, p=.10, ηp2=.04) or valence 
(F(1,65)=1.08, p=.3, ηp2=.02).  There was also no interaction between group and valence 
(F(1,65)=.66, p=.42, ηp2=.01).  That is, there was no significant difference in controlled 
allocentric performance, both overall and across groups and valence conditions.  
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Figure 7. Mean controlled allocentric performance by group and valence condition. Error 
bars represent 95% CI for mean. 
 
4.4.1 Sex & order 
As for the 2x2x2 model, sex was added to the model.  The main effect of sex was 
not significant (F(1,63)=.76, p=.39, ηp2=.01), nor were any interactions (all ps>.05).  
Performance was similar, overall and across groups and valence conditions, for men and 
women.  This was also true when presentation order was added to the model (without 
sex).  The main effect was not significant (F(1,63)=1.79, p=.19, ηp2=.03), nor were any 
interaction terms (all ps>.05).  The order in which stimuli were presented did not make a 
difference to controlled allocentric performance, both overall and across groups and 
valence conditions. 
 Predictors of controlled allocentric performance for people with 
depression 
This was an exploratory analysis to identify predictors of controlled allocentric 
performance for people with depression.  Hierarchical multiple regressions were 
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conducted.  Potential demographic confounds (age, sex, English as a first language, 
employment and education) formed the first block.  Employment (employed; unemployed 
or student) and education (less than degree level; degree level or higher) were collapsed 
into two categories for ease of interpretation.  The second block contained depression 
(BDI-I) and anxiety (GAD-7) symptomology scores.  The third block contained depression 
characteristics (total number of depressive episodes, time since first episode, length of 
current episode, whether medication is being taken, whether undergoing talking therapy 
and whether a first or second degree relative had a history of depression).  The multiple 
regression was conducted for overall controlled allocentric performance (calculated by 
averaging neutral and negative valence conditions), and for neutral and negative valence 
conditions separately. 
Table 3 
Results of hierarchical regression of controlled allocentric performance for people with depression 
 Overall   With neutral stimuli  With negative stimuli 
 F/FΔ df R2/R2Δ  F/FΔ df R2/R2Δ  F/FΔ df R2/R2Δ 
Block 1            
Demographic 
variables 
4.37* 5,21 .51  2.14 5,21 .08  5.87* 5,21 .58 
 
Block 2 
           
Symptomology 
variables 
.79 2,19 .06  .46 2,19 .05  2.05 2,19 .07 
 
Block 3 
           
Depression 
characteristics 
.74 6,12 .12  1.20 6,12 .16  .64 6,12 .08 
            
Reduced model 6.76** 2,30 .31  - - -  10.91** 2,30 .42 
Age + sex 
 
           
Block 1: test statistics = F, R2    Blocks 2 & 3: test statistics = FΔ, R2Δ (model change)      *p<.01     **p<.001 
Table 4 
Reduced regression models of controlled allocentric performance for people with depression 
 
 
 
 Overall   With negative stimuli  
 t p β  t p β 
         
Age 2.35 .03 .36  3.12 .004 .43  
         
Sex 2.75 .01 .42  3.37 .002 .47  
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Table 3 summarises the results of the hierarchical regression. For both overall 
controlled allocentric performance and performance with negative stimuli, only the model 
containing potential demographic confounds was a significant predictor, addition of the 
other blocks of variables did not significantly add to the model’s predictive power.  For 
controlled allocentric performance with neutral stimuli, it was not possible to predict 
controlled allocentric performance with neutral stimuli with any of the variables entered 
into the model.  Other factors must have accounted for variability in performance in this 
condition. 
For both overall controlled egocentric performance and with negative stimuli, the 
reduced model contained the two variables that significantly predicted performance: age 
and sex (Table 4).  For both, sex had the strongest relationship with performance.  There 
were no issues with collinearity in either model (tolerance >.1 and VIF <10 for both 
variables).   
The reduced model regression equations were:  
Overall controlled allocentric performance = -21.08 + .35 age + 10.34 sex 
Controlled allocentric performance with negative stimuli = -28.33 + .54 age + 14.56 sex 
For both, the negative constant implied controlled allocentric performance was 
impaired compared to egocentric.  According to the equations, increasing age improved 
overall controlled allocentric performance by .35% per year, and by .54% per year of age 
with negative stimuli.  Being female (coded as 1) increased overall performance by 10.34% 
and by 14.56% with negative stimuli, compared to being male.  Effects on overall 
performance were the opposite to what would be expected from previous research (Raz, 
Ghisletta, Rodrigue, Kennedy & Lindenberger, 2010; Persson et al., 2013). 
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 Associations with neuroticism 
Pearson correlations were used to investigate associations between control group 
performance and control group neuroticism scores on the TIPI.  There were no significant 
correlations between neuroticism scores and performance on the Town Square Test, by 
valence, viewpoint, valence and viewpoint, controlled allocentric performance by valence 
or total controlled allocentric performance (all ps>.05). 
 
5 DISCUSSION 
This study used a word-based version of the Town Square test to investigate the 
relative effects on hippocampus-dependent allocentric memory of using neutral and 
negatively valenced stimuli, for a depression group and control group.  The aim was to 
bring together for the first time research showing memory biases towards negatively 
valenced stimuli and impairments in allocentric memory performance amongst people with 
depression to allow their interaction to be investigated.  This section will first provide a 
summary of the results, relating these back to the study’s aims and hypotheses, before 
looking to provide some insights into the pattern of results.  It will then consider 
limitations, clinical implications and finally suggestions for future research. 
 Summary of research findings: primary aim 
The primary aim of the research was to investigate any effects on Town Square 
Test performance of using neutral and negative stimuli and any differences between 
depression and control groups.  As this was the first time this interaction had been studied, 
one tentative hypothesis was proposed for neutral stimuli.  Following Wong’s (2015) 
findings, it was predicted that, for people with depression, performance would be worse in 
the shifted view condition because of impairments in hippocampal functioning required for 
allocentric processing in the shifted view condition than the same view (Schmaal et al., 
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2015).  The control group would show no significant difference between shifted and same 
viewpoint performance.  The impairment in shifted view for people with depression would 
also impact on allocentric processing when egocentric processing was controlled for, which 
would be worse than for healthy controls. 
For negative stimuli, two alternative hypotheses were tested.  The enhancement 
hypothesis, based on the modulation hypothesis (Dolcos et al., 2004), predicted people 
with depression would perform significantly better with negative stimuli in the shifted view 
condition, both when compared to the same view condition and to healthy controls.  This 
would also be reflected in controlled allocentric performance, which would be better for 
people with depression than healthy controls.   
The interference hypothesis, based on the affective interference hypothesis 
(Gottlib & Joorman, 2010), predicted people with depression would perform significantly 
worse in the shifted view condition with negative stimuli, both when compared to 
performance in the same view, and to healthy controls.  Controlled allocentric performance 
would also be significantly worse for people with depression than healthy controls.   
While it could be said there was evidence to support the hypothesised lack of 
difference between shifted and same view performance for control participants with 
neutral stimuli, there was no evidence to support other predictions.  The only effect of 
valence found in any analysis was an order effect, whereby participants performed better 
overall with neutral than negative stimuli when negative stimuli were presented first.  
There were no other effects of valence for either group in terms of same view (egocentric), 
shifted view (uncontrolled allocentric) or controlled allocentric performance.  A main effect 
of viewpoint was found, whereby participants performed worse on the shifted than the 
same view condition.  However, there were no interactions between viewpoint, group and 
valence, that is viewpoint made a difference only at the overall performance across valence 
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conditions and groups level; there were no differences between groups and valence 
conditions.   
There was also a trend towards people with depression performing better in the 
shifted viewpoint condition than same.  This led to sex being added to the model and a sub-
analysis looking only at women.  Women with depression performed better than controls 
in the shifted viewpoint (uncontrolled allocentric) condition, but not in the same.  
However, once again, there were no valence effects. 
For order, there were no differences between viewpoint conditions and no 
difference between groups.  There was also no order effect for controlled allocentric 
performance.  Stimuli order was randomised due to evidence of a carryover effect in 
affective bias research (Siegle et al., 2002).  When people with depression are exposed to 
negative stimuli, the enhanced memory effect can persist beyond presentation, affecting 
performance on later trials.  The order effect found whereby participants performed better 
overall with neutral than negative stimuli when negative stimuli were presented first, 
would suggest a similar carryover in this study.  However, given the lack of interaction with 
either group or viewpoint plus the null results in terms of valence effects on performance 
elsewhere, it was difficult to provide an explanation or be more than tentative.   
 Summary of findings: secondary aim 
The secondary aim was to explore predictors of controlled allocentric performance 
for people with depression.  Only age and sex were found to predict any type of 
performance, predicting both overall performance and with negative stimuli.  None of the 
clinical variables showed any influence on performance.  The lack of association with 
number of depressive episodes did not support the recent meta-analysis (Schmaal et al., 
2015), which found this predicted hippocampal damage.  However, the lack of association 
with depression symptomology, co-morbid anxiety and use of anti-depressants did support 
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the findings (Schmaal et al., 2015).  Wong (2015) also found no association between 
performance and depression severity or time since first episode, but the study did find an 
association with anxiety symptomology, unlike here.  However, given the lack of valence 
effects in the main analysis, these supportive findings should be interpreted cautiously.  
In terms of sex being a predictor, this supported the finding that females with 
depression performed better in the shifted view condition when compared to control 
group females.  For both overall controlled allocentric performance and with negative 
stimuli, being female predicted better performance.  It was not, however, a predictor of 
controlled allocentric performance with neutral stimuli.   
The age effect was also interesting.  In general population studies, hippocampal 
functioning has been found to decline with age (Raz et al., 2010), and indeed this is why 
age was included as a covariate in the main analyses.  However, here, as age increased, so 
did overall controlled allocentric performance and with negative stimuli.  Schmaal et al. 
(2015) did not find age was a moderator of reductions in hippocampal volume.  Early onset 
before the age of 21 was associated with smaller hippocampal volumes, suggesting it was 
age factors relating to depression that impacted on hippocampal volume, rather than the 
person’s age per se.  This would allow for different age effects on hippocampally-
dependent spatial functioning for people with depression than the general population.   
 Balancing alternative hypotheses 
Two alternative sets of hypotheses for the interaction between valence and 
allocentric memory performance with negative stimuli were proposed with two different, 
and opposite, sets of predictions.  The results of this study supported neither.  There were 
three possible explanations for this.  One was that both potential effects – enhancement 
and interference – occurred simultaneously, cancelling each other out and accounting for 
the null results.  Another was that one or other was correct but confounds in the study 
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design meant effects were not seen.  Finally, that neither was correct and the null effects 
were attributable to other factors. 
 Potential confound: use of words 
To attempt to account for the null results, a number of potential confounds in the 
study were considered.  The first, and perhaps the most important, was the use, for the 
first time, of words within the Town Square Test.   
Clearly, reading words uses different cognitive processes to processing images.  
Reading English words uses the working memory’s phonological loop and does not require 
visuo-spatial analysis to process images (Baddely, 1986).  It has been suggested spatial 
location information is therefore more likely to be automatically encoded with memory 
representations of images than words (Pezdek, Romow & Sobolik, 1986) and there is 
evidence spatial memory for images is better than for English words (Pezdek et al., 1986).   
While both processes involve both sides of the hippocampus, there is a tendency for 
different areas to be involved to a greater or lesser extent.  The right hippocampus has a 
central role in non-verbal visual memory (Milner, 1968) as well as spatial location.  The left 
hippocampus is more involved in processing verbal information (O’Keefe and Nadel, 1978). 
However, as words were used for all conditions in the Town Square Test, this could 
not account for the null results, and so confounds related to words used need to be 
considered.   
5.4.1 Potential word confound: valence and arousal 
There is evidence to suggest valence and arousal have different effects on memory, 
utilising different cognitive and neural processes.  Kensinger and Corkin (2004) used a word 
recognition paradigm with healthy participants.  Words were either neutral, arousing 
negative (e.g. rape, slaughter), or non-arousing negative (e.g. sorrow, mourning).  
Participants remembered more negative words than neutral, whether or not they were 
101 
 
arousing.  However, using imaging, the study found different brain networks were used for 
arousing and non-arousing negative words.   
For arousing words, and in line with the modulation hypothesis, an amygdala-
hippocampus network was activated.  With stimuli that were valenced, but not arousing, a 
different network of brain areas was involved, the prefrontal cortex and hippocampus.  The 
amygdala-hippocampus network is relatively automatic and linked to an assessment of 
threat.  A secondary encoding task competing for resources did not interfere with this 
effect.  The prefrontal cortex-hippocampus network is involved in more controlled and 
elaborative encoding, such as autobiographical or semantic elaboration or extra rehearsal.  
It is therefore less automatic and the effect on memory was reduced with a concurrent 
task.  The authors suggested confounding arousal and valence could help explain 
contradictory findings within the literature (e.g. Dolcos, Graham, LaBar & Cabeza, 2003; 
Hamann, Ely, Grafton & Kilts, 1999).   
The importance of arousal is supported by Mather et al. (2006), when pictures 
were used in a spatial location memory test.  Valence did not affect recognition memory 
for location, but arousal did, with location memory reducing as arousal increased.   
Kensinger and Corkin’s (2004) findings may have implications for the findings of 
this study, while noting theirs was a word recognition and not a spatial memory task and 
also involved healthy controls rather than depressed participants.  In the current study, 
words were taken from a normed database of valence ratings (Warriner et al., 2013) and 
arousal was not controlled.  The list included words that could be considered to be arousing 
and non-arousing.  Arousal could therefore have acted as a confound.   
Here, processing valence was task-irrelevant and so the Town Square Test itself 
could be seen as a competing task.  With arousing, negatively valenced words, the 
concurrent demands of the spatial memory task would not interfere with the automatic 
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enhanced memory effect due to activation of the amygdala-hippocampus network.  It 
could therefore be hypothesised, performance on the spatial memory test would be 
enhanced, as suggested by the modulation hypothesis.  With non-arousing, negatively 
valenced words, the spatial memory task would interfere with the more elaborate 
encoding processes of the prefrontal cortex-hippocampus network, and no enhanced 
memory effect would occur, as suggested by the affective interference hypothesis.  If there 
was a similar proportion of arousing and non-arousing stimuli, these two effects may have 
cancelled each other out, accounting for the null effects.  This would certainly warrant 
further investigation in future studies, comparing arousal as well as valence conditions to 
see whether a negative, high arousal condition would produce results in line with the 
modulation hypotheses.   
5.4.2 Potential word confound: valence not processed 
Another potential reason for the lack of effects is that valence was not processed.  
Valence was irrelevant to the task.  In an attempt to prompt people to process valence as 
well as location, participants were told they would be asked to rate word valence at the 
end of the task.  This may not have been enough.  How far this could attribute for the null 
findings is debatable.  It has been suggested assessment of valence is pre-attentive, 
occurring automatically as part of our threat appraisal system and involving the amygdala 
(Öhman, 1992).  When people were asked to physically encode stimuli (e.g. count vowels), 
valence only led to enhanced recognition memory with positive stimuli, there was no effect 
for negative stimuli.   With more effortful, semantic processing, the bias disappeared 
(Ferré, 2003).  The authors drew on mood-congruence at the time of encoding (Bower, 
1981) to explain this finding.  Because this bias is at the level of encoding and pre-attentive, 
it disappears with effortful, semantic processing.   
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This could account for the lack of valence effect within the control group, as only 
neutral and negative stimuli were used.  Control participants may, therefore, not have 
processed valence, automatically or otherwise.  While this research has not been replicated 
for a depression group, applying the same assumptions of mood congruence, it would be 
expected that the depression group processed valence with negative stimuli but not 
neutral.  In this case, other potential confounds, such as arousal and valence may have 
come into play to account for the null results.  Repeating the study, controlling for arousal, 
may allow these effects to be isolated. 
5.4.3 Potential word confound: subjective valence 
While participants were asked to rate word valence, it was not possible within the 
time limits of this study to input and analyse these data.  What is more, the collection of 
participants’ subjective valence ratings was only originally intended to be a manipulation to 
encourage participants to process stimuli valence, there would also be concerns about the 
quality of these data.   
As words were supposed to be negative or neutral, responses would have been 
expected to be between 1 (completely unhappy) and 5/6 (neutral).  However, a visual 
check suggested a broader range of responses, including positive ratings up to the 
maximum of nine.  Word valence is of course subjective and will be influenced by 
experiences brought to mind by the word.  It would be interesting to explore whether 
subjective valences of words rated as neutral within the database (Warriner et al., 2013) 
are influenced by depression.   
As the depression group had been asked about their depression history at the start 
of testing, this may have been activated and have affected the rating of purportedly neutral 
words.  Other studies with valenced stimuli used participant valence ratings as a variable in 
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the analysis (e.g. Kensinger & Corkin, 2004).  It would be interesting to see in future studies 
if using individuals’ own ratings of valence would produce the hypothesised effects. 
5.4.4 Potential word confound: types of words used 
The list of words used in the Town Square Test was a mixture of concrete nouns 
(e.g. barrel, maggot) and adjectives and adverbs (e.g. mouldy, cunning; see Appendix D). 
Clark and Teasdale (1985) found, for people with depression, bias towards negative words 
was strongest for negative trait adjectives than other kinds of words.  Therefore, types of 
words used in the study could also have acted as a confound.  
5.4.5  Potential word confound: English as a second language 
While there was no difference between the groups in numbers with English as a 
first language, differences within groups were not tested.  However, English as a first 
language was not a predictor of performance for people with depression.  Researchers 
were occasionally asked during the valence rating task if it was acceptable for participants 
without English as a first language to translate words into their native language to assess 
their emotional reaction.  It would be interesting to repeat the study with a group of native 
English speakers to assess any possible confounding effects.    
 Potential confound: co-morbid anxiety 
Of the depression group, 80% met criteria for co-morbid GAD.  There is a paucity of 
research looking at how the presentation of depression may differ with co-morbid anxiety.  
Wong (2015) found increased anxiety in the depression sample was associated with 
reduced controlled allocentric memory performance, and therefore an implied link to 
hippocampal impairment.  However, Schmaal et al.’s (2015) findings suggested no impact 
of co-morbid anxiety on hippocampal volumes.  Linked to the modulation hypothesis, an 
fMRI study with a valenced word memory paradigm (van Tol et al., 2012) found 
hyperactivation of the right hippocampus and amygdala during encoding of negative words 
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only for those with depression, and not with depression and anxiety.  Given high levels of 
co-morbidity in this sample, this could have contributed to the lack of valence effects on 
performance.   
High levels of co-morbid anxiety precluded any subanalysis.  It would be worth 
samples for future studies having a better balance of people with and without co-morbid 
GAD as there may be differences in how valence affects performance that would be worth 
exploring.   
  Sex 
This study produced three interesting sex differences warranting further 
investigation.  Firstly, women with depression performed better in the shifted view 
condition than women in the control group.  Secondly, being a woman with depression 
predicted better overall controlled allocentric performance and with negative stimuli.  
Thirdly, sex was not a predictor of performance with neutral stimuli.  There are sex 
differences in depression.  Women are twice as likely as men to have depression (Kessler, 
McGonagle, Swartz, Blazer & Nelson, 1993; Kuhnert, 2003) and show different 
symptomology, for example more insomnia, somatic symptoms, and increased 
appetite/weight gain (Schuch, Roest, Nolen, Penninx & de Jonge, 2014). Whether there are 
sex differences in memory or cognitive biases found for people with depression is under-
researched.  Some behavioural affective memory studies (e.g. Siegle et al., 2002) found no 
differences in terms of sex and there were no sex differences in hippocampal volume 
impairment in Schmaal et al.’s (2015) meta-analysis.  However, many studies did not look 
at sex differences (e.g. Mather et al., 2006).  For the general population, there is evidence 
of a male advantage in spatial memory (e.g. Persson et al., 2013), but some studies found 
women performed better in object location tests when there was also a verbal component 
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(Voyer, Postma, Brake, & Imperato-McGinley2007), as there was here, which may help to 
explain this finding.   
The study’s sample size precluded any subanalysis to see whether females with 
depression were different demographically to control group females, or clinically from 
depression group males.  However, the lack of associations between variables other than 
age and sex with controlled allocentric performance may suggest, even if this analysis had 
been possible, differences in these variables would not account for the enhanced 
performance of females with depression.  Future studies with larger sample sizes allowing 
sex differences to be more fully explored would therefore be desirable. 
 Additional limitations 
5.7.1 Sample size 
The sample size was in line with the power analysis and therefore the study should 
have been sufficiently powered to detect a small to medium effect.  However, the sample 
size did preclude certain subanalyses that may have helped to develop explanations for the 
unexpected null effects, including investigation of sex effects. 
5.7.2 Self-report of depression history 
The study used self-report to gain participants’ depression history.  This 
information was not clinically corroborated.  It was clear participants found questions such 
as number of previous depressive episodes difficult to answer accurately.  This difficulty 
increased with the length of time taken to receive a formal diagnosis.  For many, formal 
diagnosis confirmed their own assessment of subjective mood over a number of years.  The 
estimate of episodes therefore included the pre-diagnostic period, and was not clinician 
endorsed.  It is difficult to know how this might be addressed in future, but it certainly 
limited the accuracy of clinical data used in the analysis. 
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5.7.3 Use of mnemonic strategies 
The use of words in the Town Square Test was also intended to reduce the use of 
mnemonic strategies to provide a purer indication of hippocampally-dependent 
performance.  Use of strategies was not routinely asked about but some participants, who 
performed particularly well on the test, reported using strategies, for example using words 
to develop stories linked to their position relative to the four corners of the courtyard.  
While it is not known how far such strategies were used, they could have acted as a 
potential confound on performance.  Future studies could consider specifically asking 
about strategy use so their influence on performance could be tested. 
 Clinical implications 
The impact of valence on allocentric spatial memory is an important question to 
answer as it may help elucidate some of the mechanisms underlying depression, given links 
to hippocampal functioning and how this may account for memory effects, most notably 
OGM.  Increasing knowledge may lead to more effective therapeutic approaches, 
improving rates of remission and relapse.   
Unfortunately, the lack of valence effects, and confounds potentially accounting for 
the null results, means further research into the interaction between valenced stimuli and 
hippocampally-dependent spatial memory is necessary before any clinical implications can 
be explored. 
 Further studies 
A number of suggestions have been made for further studies in this area.  Perhaps 
most important would be to control for arousal and use participants’ own subjective ratings 
of valence in the analysis.  Finally, a larger sample size, one with more people without co-
morbid anxiety, would allow this, and potential sex differences, to be explored.   
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 Conclusion 
While mood congruent effects in depression are well documented, the nature of 
these differs depending on a number of factors, including the task-relevance of valence, as 
does the theoretical approaches recruited to explain them.   The aim of this study was to 
investigate the effects of valenced stimuli on hippocampally-dependent allocentric spatial 
memory to further elucidate these effects.  However, no effects of valence were found on 
performance on the Town Square Test, for either a depression group or healthy controls.  
Hypothesised reasons for these null results included: confounding valence and arousal; a 
lack of processing of valence; the subjective nature of valence; and the presence of high 
levels of co-morbid anxiety in the depression group.  For this reason, further research is 
required, so the influence of some of these potential confounds can be explored.  This 
would be important to do given the potential clinical implications for research in this area, 
in terms of improving understanding of the cognitive and neurobiological processes 
underlying depression, which may in turn lead to improvements in treatment approaches. 
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PART 3: CRITICAL APPRAISAL 
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1 Introduction 
This critical appraisal will focus on the major research project but will include some 
brief reflections on the literature review at the end.  It will cover the following areas: 
experiences of doing a joint project; developing a word-based version of the Town Square 
Test; recruitment issues; issues with screening and testing; and the researcher therapist 
divide.  It will end with some brief reflections on both the major research project and the 
literature review. 
2 Experiences of doing a joint project 
I found doing my DClinPsy major research project jointly with another researcher 
incredibly effective.  My joint researcher and I very quickly formed a good working alliance, 
one we managed to maintain throughout the project, even when we faced challenges with 
recruitment.  I found there were many advantages to doing a joint project.  From a practical 
point of view, sharing data collection meant we were able to have a bigger sample size and 
a specifically recruited control group, both improvements on the previous trainee’s (Wong, 
2015) project using the Town Square Test (King et al., 2002) with a depression group.  It 
was always useful to be able to talk through decisions that needed to be made about 
measures, procedures and many other aspects, and developing the protocol for the study 
was very much a joint effort.  The joint researcher’s counsel was always valuable and 
useful.   
When we were recruiting the depression group, the joint researcher and I had 
complementary placement days.  This meant we could offer testing on more days 
increasing the chances of turning successful screening into completed testing 
opportunities.  It also gave us more flexibility to offer to attend team meetings at the 
different locations of the Improving Access to Psychological Therapies (IAPT) service so we 
could present the project to clinicians.  Some of the testing locations were quite difficult for 
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me to get to, but were closer to where the joint researcher lived, and so we agreed to split 
testing locations to ensure commuting times were not prohibitive for either of us.  This is 
just one example of the pragmatic and ego-free working relationship we managed to forge. 
The advantages of doing a joint project were not just practical.  I believe my stress 
levels were significantly lower than they would have been if I had been doing the project 
alone.  Not only was I able to share the tasks of the project, but I also had someone to voice 
and share frustrations with, as well as share the relief and achievement of meeting key 
milestones.  I believe we motivated each other to keep going when recruitment for the 
depression group was proving long and arduous.  Left to my own devices, I think I would 
probably have stopped earlier and settled for a sample size smaller than the one indicated 
in the power analysis as being the optimal one.  But together we persevered and I am 
proud we managed to test all the participants in our original plan.     
3 Developing a word-based version of the Town Square Test 
When the decision was made for my project to investigate how differently 
valenced stimuli might affect performance on the Town Square Test, initially my supervisor 
and I planned to develop a new version with valenced images as images had been used on 
the Test to date.  There are a number of image databases with normalised valenced ratings, 
including the International Affective Picture System (IAPS; Lang, Bradley, & Cuthbert, 1999).  
Another University College London researcher who had used the Town Square Test before 
(Bisby, King, Brewin, Burgess & Curran, 2010) had piloted a version using valenced images 
taken from IAPS, but had not used it in a study.  He told us he had found participants were 
not completely engaging with the valence of the images as this was secondary to task 
performance.  In discussion with my supervisor, we identified several additional drawbacks 
with using valenced images.  Within the Town Square Test, the placeholders stimuli are 
presented on are on the floor of the virtual environment.  Some of these are at the back of 
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the Square.  At this distance, my supervisor and I considered it would be difficult, especially 
at low image resolutions, to know with any level of certainty what the image was, including 
its valence.   With previous versions, the nature of the image had not been important.  
However, with this version, it would be important for people to consistently and quickly 
recognise the image and its valence. 
My supervisor then suggested using words rather than images.  He found a normed 
database (Warriner, Kuperman, & Brysbaert, 2013) and I used this to develop a list of 
potential words.  I did research into reading words as I did not want reading time for words 
to be a confound.  Research by New, Ferrand, Pallier and Brysabaert (2006) found a U-
shaped function when assessing reaction times in a naming task.  Reaction times were the 
same for words between five and eight letters and so it was agreed to select words of this 
length.  When the words were put onto the placeholders in the Square, words of eight 
letters sometimes overlapped when the four options were shown close together in the test 
condition, and so words of eight letters were removed from the set.  As New et al. (2009) 
also found an inhibitory effect of 20m/s per syllable, disyllabic words were selected.  My 
supervisor and I agreed to not formally control frequency, for example by using frequency 
ratings, but prioritised intuitively higher frequency words.  In terms of the font used, there 
is evidence of no difference in reading speed between a fixed width font (e.g. Courier New) 
or a variable width font (e.g. Arial; Rayner, Slattery & Bélanger, 2010).  Therefore, the font 
was chosen for clarity from the rear of the Town Square virtual environment. 
When the selected words were put into the virtual environment, we considered 
them to readable even at the placeholders at the back of the Square.  I highlighted, as the 
other researcher had found when piloting the valenced picture version, that the word itself 
was not vital to the task just its location, and there was therefore no need for people to 
process the valence of the word.  We agreed the manipulation whereby people would be 
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told to pay attention to how the word made them feel before doing the Town Square Test 
so they could rate the words when given a list at the end. 
It is difficult to know whether this manipulation was sufficient for people to process 
task-irrelevant word valence, or whether this in part accounts for the unexpected null 
results.   We changed the Test in two ways concurrently: using words rather than images; 
and manipulating word valence.  With hindsight, perhaps we should have investigated 
using words for the images used in the image based Town Square Test as the neutral word 
condition.  Then we could have compared performance on this with the image based 
version.  However, the valence of the original images was not controlled and we may have 
found the words for some of the images used were not have rated as sufficiently neutral on 
the normed word database (Warriner et al., 2013). 
People’s emotional reaction to words, and images, is subjective.  We did ask people 
to rate the words after they had completed the Town Square Test.  However, because 
recruitment of the depression group took longer than anticipated, it was not possible 
within the time constraints of the project to analyse these ratings separately.  I did have a 
look at the rating sheets and they suggested people did not necessarily rate the words in 
line with normed valence ratings.  If participants were rating the words in line with the 
norms, the maximum rating would be 6 (out of a possible 9, with 9 indicating a word 
making people feel completely happy).  It was clear from looking at the rating sheets some 
participants rated some words as having clear positive valence, using the highest possible 
score of 9.  It would be interesting to use people’s subjective ratings of valence to classify 
the words and see if this made a difference to the analysis.   Several other studies have 
used this approach (Kensinger & Corkin, 2004). 
Words were also chosen to minimise any mnemonic strategies used by participants 
to remember the locations as these would mean performance was less reliant on 
125 
 
hippocampal processing.  There was anecdotal evidence that some people were using 
strategies.  One woman I tested, who did particularly well on the test, told me she used the 
words to develop stories linked to the four corners of the town square to help remember 
locations.  The relatively large number of test items in predictable formats might encourage 
participants to develop such strategies to improve test performance.  It is therefore difficult 
to know what changes could be made to further reduce the use of strategies that might 
interfere with the Town Square Test’s ability to provide an indication of hippocampally-
dependent allocentric memory. 
Previous studies using the Town Square Test have used two list lengths of three 
and six items for the same and shifted view conditions (e.g. Wong, 2015; Smith, Burgess, 
Brewing & King, 2015).  They have consistently found no difference in performance 
between the list lengths.  This study had four conditions, with four combinations of valence 
and viewpoint (same-neutral, same-negative, shifted-neutral, shifted-negative), rather than 
the simpler two viewpoint conditions of previous studies.  We therefore decided to have 
just one list length of six, to keep the total number of trials manageable.  Even then, there 
were a total of 96 trials, 48 each for neutral and negative valence, with four blocks of six 
trials at same viewpoint and four of six for the shifted viewpoint. 
4 Recruitment issues 
When planning project recruitment, the joint researcher and I had anticipated 
recruitment of the control group might be more problematic than the group with 
depression.  We had links with an IAPT service which had been used for UCL DClinPsy 
research before and felt confident we would meet our recruitment targets quickly.  The 
depression group recruitment proved to be difficult and labour intensive, and took far 
longer than anticipated.  We finally finished recruitment and testing of those with 
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depression at the end of March 2017.  Our initial target had been the end of December 
2016. 
We had understood the last trainee had issues with referrals from clinicians which 
had held up recruitment of people with depression.  We also understood, once the trainee 
had access to the service’s list of people who had consented to being contacted for 
research purposes, she quickly recruited the final participants to her study.   We therefore 
knew how important it was to gain early access to the research list. 
There were a few delays to starting recruitment of the depression group.  Firstly, 
the previous IAPT contact had left the service and so we had to identify someone else who 
could act as a sponsor for our research.  We made contact with our new sponsor at the end 
of May 2016.  The research had been presented by the previous contact and the service 
had agreed to support it in July 2015.  However, when our new sponsor came on board it 
became apparent it would need to be re-presented at a research meeting.  This finally 
happened in July 2016, where, once again, the service agreed to support the research.      
Access to the research list was also delayed.  We got access to the list at the end of 
September 2016.  We were therefore initially reliant on referrals from clinicians.  As agreed 
with our research sponsor, we presented our research at service team meetings (one in 
August 2016, but it was not possible to get a slot at another site until December 2016) and 
we made laminated cards summarising the research and criteria for participation for 
clinicians to keep on their desks as reminders.  We had several meetings with the sponsor 
to discuss recruitment and to find out if there was anything more we could be doing to 
keep front of mind among clinicians at the different service sites.  Overall, through this 
process, we received two referrals, one of which was not eligible.  The previous trainee had 
received 17 referrals through this route, although seven were not eligible.  I am not sure 
why we received so few clinician referrals.  The sponsor implied there were a number of 
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concurrent research projects looking for clinician referrals and we might simply have been 
at the end of a long list. As these projects came to an end, we thought more clinician 
referrals would start to come through but this did not happen.  The sponsor e-mailed 
certain clinicians who he thought might have appropriate clients, but even this direct 
contact did not increase clinician referrals.   
This meant we were almost completely reliant on the list of people who had 
consented to being contacted for research purposes.  Using this list turned out to be very 
labour intensive, involving several steps.  We had a research assistant at the service who 
was responsible for providing us with lists taken from the service’s central database.  We 
provided the eligibility criteria for the research and discussed them on the phone.   Lists 
were drawn at regular two to four week intervals across the recruitment period.  When we 
received the lists, we needed to check them against inclusion criteria: aged under 65, with 
a PHQ-9 (Patient Health Questionnaire-9; Kroenke, Spitzer & Williams, 2001) score of more 
than 10.  We then needed to ascertain where they were on the service’s care pathway.  
Increasingly we found people on the lists had not yet been assessed or had not started 
therapy, or had been assessed but had been deemed to be inappropriate for the service 
and were in the process of being discharged.  We had agreed, to effectively manage any 
emerging risk, we would not see people who had been discharged.  We also did not contact 
people who scored more than 1 on question 9 of the PHQ-9 which asks about suicidality.  
The lists therefore held diminishing returns over time as we had to exclude more and more 
potential participants.   
We then e-mailed potential participants with a summary of the study from my 
secure NHS e-mail account.  Initially, we waited for people to contact us to say they were 
interested but increasingly realised very few people were spontaneously getting in touch, 
perhaps unsurprising given they had depression.  We therefore started to make follow-up 
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calls to people we had e-mailed to ask them if they had seen the e-mail and to assess 
interest in participation.  This was fruitful, but had a low call to contact ratio and was 
something neither I nor the joint researcher enjoyed doing. 
Recruitment was sporadic.  At times, we would become quite concerned about 
numbers but then we would have a flurry of contacts, successful screenings and testings, 
which we would find encouraging, only for our next set of e-mails to not generate as many 
contacts.  In total, we e-mailed 282 people from the lists and screened 60, a response rate 
of 21%.  Of these, 21 were not eligible, a rejection rate of 35%.  Of the 39 who passed 
screening, we completed testing with 36, the other three cancelled appointments and it 
was not possible to rearrange.   Of these, 33 were included in my analysis: one was left 
handed and two did not complete the Town Square Test.  So, from initial e-mail contact to 
participant included in analysis, the response rate was 12%.  Ultimately, it was a relief to 
meet our final recruitment target of end of March 2017.   
5 Issues with screening and testing 
At one point, the number of people with depression who did not meet inclusion 
criteria during telephone screening reached approximately 50%.  This could be for a few 
reasons but most commonly because of co-morbid conditions, including psychosis.  Given 
the length of time recruitment of this group was taking, this was frustrating as well as 
concerning.  If the proportion being screened out had stayed the same, I don’t believe it 
would have been possible to meet the numbers indicated by the power analysis within the 
necessary timeframe.  The exclusion criteria in terms of co-morbidity had been set to 
minimise possible confounds.  For example, a study (Smith et al., 2015) found people with 
post-traumatic stress disorder (PTSD) showed a similar deficit in performance in the Town 
Square Test versus healthy controls as found by Wong (2015) for people with depression.  
It was therefore important to ensure people with depression did not have co-morbid PTSD.   
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In many ways, it would have been desirable for the sample not to have co-morbid anxiety 
as this could also have acted as a confound.  However, as 80% of the sample met clinical 
thresholds for GAD as measured by the GAD-7 (Generalised Anxiety Disorder-7; Spitzer, 
Kroenke & Williams, 2006), it would have been very difficult to recruit a depression sample 
without co-morbid GAD.  Luckily, over time, the percentage of people being screened out 
fell and fewer were rejected at this stage.  Overall 35% of those screened did not meet 
eligibility criteria and had to be excluded.   
One potential participant complained about a screening call with the joint 
researcher.  He did not meet some of the early criteria and so, according to our protocol, 
the joint researcher had ended the call after informing the participant they were not 
eligible to participate.  The potential participant was unhappy with the way the call had 
been ended and e-mailed me to complain.  The crux of his complaint appeared to be that 
the co-morbid disorder leading to him being excluded from our research was something 
that had resulted in him being excluded from many other things across his life.  We 
informed our supervisor and the sponsor at the service and agreed I would call him to 
apologise.  We hypothesised his concerns were not about how the joint researcher had 
conducted this specific call, but a broader issue of exclusion faced by the potential 
participant, and indeed many with mental health issues.  This turned out to be the case 
when I spoke to the potential participant, and he was reassured and grateful for the call.  
After this, however, we did adjust our screening procedure for the depression group.   We 
made sure we briefly explained why we have eligibility criteria in research (to reduce 
potential confounds) and that, if it became clear the potential participant did not meet 
criteria, we would end the call then and not take up more of their time than necessary.  We 
had no further incidents.   
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At first, we did not include the need to be right handed in the initial e-mail we sent 
to potential depression group participants.  This was an oversight.  We had one participant 
who, it emerged during the screening call, was left handed.  When we told her one of our 
criteria was that participants needed to be right handed, she queried this.  We sought the 
advice of our supervisor and we agreed, given it was our oversight to not specify 
handedness in the initial e-mail, that we would include the person for testing.  There is also 
some debate within the research community about the inclusion of left-handed 
participants in research using these kinds of tests (Willems, Van der Haegen, Fisher & 
Francks, 2014).  Some suggest, given left handed people make up roughly 10% of the 
population, knowing how left-handed people perform in these tests is useful information 
(Willems et al., 2014).  However, as this was the only left-handed person in the cohort, I 
excluded this person’s data from the analysis.  Left-handedness could have acted as a 
confound and there would be no opportunity for any subanalysis comparing the 
performance of left and right handers.    We then ensured the initial e-mail included being 
right handed as an inclusion criterion. 
In terms of issues with the testing of participants, one of the depression group 
participants told me, if she did the spatial memory tasks, she would be guessing as she had 
“no spatial awareness” and would therefore be performing at or around chance.  Testing was 
therefore terminated.  With another depression group participant tested by the joint 
researcher, the Town Square Test programme crashed and so it was not possible to complete 
the test.  Given two of the tests involved using a laptop, we were fortunate to only have one 
where technical issues meant we could not complete data collection.  Finally, one of the 
control group participants I was due to test, arrived at the testing slot clearly inebriated and 
so I had to tell him, as sensitively as possible, he would not be able to participate.  I made 
sure I was in a public area in case he did not react well to being challenged about his fitness 
to participate, but in fact he simply apologised and left. 
131 
 
6 The researcher therapist divide 
I was struck many times how difficult it can be to separate being a therapist from 
being a researcher. Some of these times occurred during the screening phase.  We used the 
SCID-I (Structure Clinical Interview for DSM Disorders; First, Spitzer, Gibbon & Williams, 
2002) to assess for co-morbid disorders.  This provides a set of questions designed around 
specific mental health conditions plus follow-up questions.  It was important to keep in 
mind that in this capacity I was a researcher and not a therapist.  At times the therapist in 
me wanted to continue to ask questions, to formulate their difficulties, when it had 
become clear, as a researcher, they did not meet criteria and so were not eligible.  The 
other time it was difficult to maintain separation was when people in the depression group 
were answering questions about their depression history.  I was struck by how many of the 
people I tested had been struggling with depression for many years but had only recently 
sought help.   
7 Reflections on the major research project 
The project investigated the interaction of two research findings: that people with 
depression have a bias in memory towards negatively valenced material (e.g. Roberson-Nay 
et al., 2006); and that people with depression have impaired hippocampal function and 
might therefore be expected to show impaired performance on tests requiring the 
hippocampus, for example spatial memory tests, as Wong (2015) had found.   
How these two phenomena might interact was much harder to predict and this is 
why alternative hypotheses were specified.   Based on research, two different potential 
hypotheses with alternative predictions of the impact of valenced stimuli on allocentric 
memory performance were proposed.  However, to find essentially no impact of valence 
for either depression or control group was unexpected and disappointing given the amount 
of time and effort put into the research.  I had hoped my research would be able to 
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elucidate cognitive and memory processes in depression, knowledge that might eventually 
improve treatment effectiveness, but I ended the process with more questions than 
answers. 
8 Reflections on literature review 
When looking for a topic for my literature review, my initial idea to look in the 
simplest terms at the links between the hypothalamic-pituitary-adrenal (HPA) axis and 
depression as I knew a little about the long-term effects of cortisol on the hippocampus 
from undergraduate psychology lectures.  However, I found a recent review had been done 
in this area (Stetler & Miller, 2011).  I then considered reviewing the links between child 
trauma and depression as this is an area of interest for me.  Again, a recent review had 
been published in this area (Carr, Martins, Stingel, Lemgruber & Juruena, 2013).   I 
therefore decided to bring these two areas together and look at the relationship between 
the HPA axis, childhood trauma and depression in adulthood.  Initial searches suggested, 
while there were a few research groups looking at this (e.g. Christine Heim, Charles 
Nemeroff and colleagues), there had not been a systematic review in this area.   
The neurobiology of the HPA axis is not an area of expertise for me, nor are the 
many ways of testing its functioning.  I spent a great deal of time researching and 
developing an understanding of the intricate and many levelled functioning of the HPA axis 
and ways of measuring it.  Due to other commitments, both on the course and outside it, 
the time I could devote to the literature review was fragmented over several months.  I was 
aware of having to spend time almost every time I came back to reviewing the papers 
identified by my search, re-educating myself about the tests and what they showed in 
terms of the functioning of the HPA axis.  With hindsight, it would have been much more 
efficient and effective to have taken larger blocks of study leave so I could achieve more 
with the knowledge I had assimilated, rather than feeling increasingly frustrated with the 
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time I was having to spend re-acquainting myself with the literature each time I came back 
to it.   
In spite of this, I am pleased with the finished review.  It was ambitious, particularly 
given my lack of knowledge in this area.  The literature is fragmented and there is a lack of 
replication or indeed overlap in terms of client groups and measures.  But important 
questions are raised by this research, questions it is currently difficult to answer given the 
lack of consistency in methodology and findings.  Some of the results potentially point to a 
sub-type of depression in adulthood linked to trauma in childhood and distinct from 
depression in the absence of a history of childhood trauma.  This could be the result of 
untreated reactions to the trauma.  Not only might this sub-type be characterised by 
different effects on the HPA axis, its existence might help explain why some people with 
depression do not respond as well as others to talking therapy, including cognitive 
behavioural therapy, and anti-depressant medication.  If future research in this area could 
help to elucidate this sub-type, it may be possible to develop a more effective treatment 
for depression with a history of childhood trauma. 
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Description of joint working arrangements 
This study was conducted jointly with Line Sagfors (trainee clinical psychologist) as 
the participant groups, including eligibility criteria, were the same for both projects.   Table 
1 provides a summary of the stages of research, indicating which were conducted jointly 
and which were conducted individually.  In terms of testing, some of the measures were 
shared and some were specific to the individual projects, and this is summarised in Table 2.  
Conducting the research as a joint project facilitated the recruitment of a sample sufficient 
to detect a small to medium effect size, according the power analyses conducted for the 
two projects, and also of a specific control group.  It also meant we could combine our 
research expense allowances so it was possible for us to financially compensate all 
participants (apart from five UCL undergraduates in the control group who received course 
credit instead) to cover travel expenses and time. 
Table 1.  
Details of stages of research conducted individually and jointly  
 Individual Joint Comments 
Literature Review X   
Empirical paper     
Research question X   
Research design  X X Initially individual, with 
collaboration on the final 
design and procedures 
Ethical approval   X Tasks conducted jointly or 
shared  
Liaison with IAPT services  X Tasks conducted jointly or 
shared 
Participant recruitment  X Tasks shared 
Participant testing  X Tasks shared 
Data scoring and input   X Tasks shared 
Data analysis  X   
Write-up X   
Critical appraisal  X   
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Table 2. 
Details of joint and individual measures  
 Joint Individual: Janice 
Williams’ project 
Individual: Line 
Sagfors’ project 
BDI-II 
 
✓    
GAD-7 
 
✓    
Bespoke clinical information 
questionnaire 
 
✓    
Demographic information 
 
✓    
TIPI 
 
 ✓   
Town Square Test (King et al., 2002) 
 
 ✓   
Four Mountains Test (Hartley et al., 
2007) 
 
  ✓  
AMT (Williams & Broadbent, 1986) 
 
  ✓  
BDI-II = Becks Depression Inventory (Beck, Steer, Ball & Ranieri, 1996) 
GAD-7 = Generalised Anxiety Disorder =-7 (Spitzer, Kroenke, Williams, & Löwe, 2006) 
TIPI = Ten Item Personality Measure (Gosling, Rentfrow & Swann, 2003)  
Town Square Test (King, Burgess, Hartley, Vargha-Khadem, & O’Keefe, 2002) 
Four Mountains Test (Hartley et al., 2007) 
AMT = Autobiographical Memory Test (Williams & Broadbent, 1986) 
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Understanding the Effects of Depression on Memory 
 
This study has been approved by the University College London Ethics Committee 
(Project ID Number): SHaPS-2014-JK-009 
 
Name, Address and Contact Details of Investigators: 
 
Principal investigator:  
Dr John King 
Research Department of Clinical, Education and Health Psychology  
University College London 
1-19 Torrington Place, London, WC1E 7HB  
United Kingdom  
+44 (0)20 7679 5993 
john.king@ucl.ac.uk 
 
Researchers: 
Line Sagfors and Janice Williams 
Doctorate in Clinical Psychology 
Research Department of Clinical, Education and Health Psychology 
University College London  
line.sagfors.14@ucl.ac.uk 
janice.williams@ucl.ac.uk 
 
We would like to invite you to participate in this research project.  
 
We would like to invite you to take part in our research study. You should participate 
only if you want to do so. Before you decide whether to take part, we would like you 
to understand why the study is carried out, what you would be asked to do, and how 
the study will be conducted. Please take some time to read this sheet thoroughly, and 
to discuss it with other people if you wish. One of our team will go through the 
information sheet with you and answer any questions you have. Please feel free to 
ask any further questions about the study, or if you find anything on this sheet 
unclear.  
 
Why is this study being done?  
 
Little is currently known about the impact of depression on the way memories are 
processed in the brain, but we know that memory can be affected. To understand the 
effects of depression on memory, we are investigating memory in both people with 
depression and people without depression. You would be tested as part of the 
group of people who are not currently suffering from depression. 
By investigating spatial memory (remembering where things are) - as well as 
autobiographical memory (remembering things we have experienced) - we hope to 
NHS TRUST LOGO 
Control group participant information sheet and consent form 
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gain a better understanding of depression and to develop more effective screening 
tools to measure the impact of depression. 
 
Do I have to take part?  
 
No. Your participation in the study is entirely voluntary. It is your choice whether or 
not you would like to participate. If you do give consent to take part in the study, you 
are still free to leave the study at any point, without giving a reason. If you leave, any 
information for the research that we have already collected from you will be 
destroyed.  
 
What will happen if I decide to take part?  
 
During a telephone call with one of our researchers, we will ask you some further 
questions to verify your eligibility. This will include questions about your mood and 
questions about whether you have had mental health problems in the past. During 
this time, any other questions you may have about your participation will be 
addressed. If you decide to participate and are suitable, the researcher will arrange a 
convenient time to meet with you at University College London.   
 
You will then complete a series of tasks and questions, some of them using a 
computer. We will ask you till fill in a short questionnaire about personality and ask 
you give some basic information about your age, sex, occupation and education. 
There will be three tasks investigating memory. One of the tasks is an 
autobiographical memory test where the researcher will give you a number of cue 
words and ask you to recall events from the past that relate to these words. You will 
then perform a pen-and-paper task in which you will be asked to view some pictures 
of landscapes, then select the correct answer from a few options. The third task is a 
computerized memory task where you will view some scenes, then answer some 
questions to see how well you remember what you saw. Most people find these tasks 
quite interesting to do. At the end of the session, the study researcher will conduct a 
debriefing and address any other questions or concerns you may have. Your 
participation should take approximately 60 minutes.  
 
 
What are the possible disadvantages and risks for taking part?  
 
We do not anticipate any potential disadvantages or risks in your participation. 
However, we will support you if you become upset or distressed during the study. 
You will be given time at the end of the study to be fully debriefed with a member of 
the research team.  
 
What are the possible benefits of taking part?  
 
You may find it interesting to complete these tasks and the information gathered 
during this study will also help to inform our understanding of depression, which 
will hopefully be a step towards helping the development of novel screening tools in 
the future.  
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Will I be paid for taking part in this study?  
 
We will give you £12.50 when you have completed the tasks and questionnaires to 
compensate you for your time and any travel expenses you may have incurred. 
 
What will happen to the results of the research study?  
 
The results will be written up in the form of reports to be submitted as a doctoral 
thesis project. As mentioned, you will not be identifiable from the results. On 
completion, you will be sent a summary of the study results if you request for it. You 
may contact one of the study researchers listed below via phone or email.  
 
All data will be collected and stored in accordance with the Data Protection Act 
1998. Only UCL researchers working with Dr. King will analyze these data. 
 
If you wish to discuss participation either before or after taking part, you can contact 
us by email or phone using the contact details at the top of this document.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
149 
 
 
CONSENT FORM 
Title of Project: Understanding the Effects of Depression on Memory 
Name of Researchers: Line Sagfors & Janice Williams  
 
Please initial all boxes  
1. I confirm that I have read and understand the information sheet for the 
above study.  I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. I have 
received the contact details for the investigators, who I can contact if I 
wish to discuss my participation.  
   
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason.  
 
3. I agree to take part in the above study.    
 
 
 
 
            
Name of Participant   Date    Signature 
                                
            
Name of Person    Date    Signature  
taking consent.  
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Understanding the Effects of Depression on Memory 
 
This study has been approved by the Research Ethics Committee for East Midlands – 
Nottingham 2 (Project ID Number): 14/EM/0222. 
 
We would like to invite you to participate in this research project.  
 
We would like to invite you to take part in our research study. You should participate 
only if you want to do so. Before you decide whether to take part, we would like you 
to understand why the study is carried out, what you would be asked to do, and how 
the study will be conducted. Please take some time to read this sheet thoroughly, and 
to discuss it with other people if you wish. One of our team will go through the 
information sheet with you and answer any questions you have. Please feel free to 
ask any further questions about the study, or if you find anything on this sheet 
unclear.  
 
Why is this study being done?  
 
 Little is currently known about the impact of depression on the way memories are 
processed in the brain, but we know that memory can be affected. By investigating 
spatial memory (remembering where things are) - as well as autobiographical 
memory (remembering things we have experienced) - we hope to gain a better 
understanding of depression and to develop more effective screening tools to 
measure the impact of depression.  
 
Why have you been invited to take part?  
 
You have been invited to take part in this study because you have recently been 
referred to (or self-referred) for depression and assessed at one of the clinical 
services in collaboration with the research team. Alternatively, you may have 
completed an intake form indicating your consent to be contacted by a researcher 
affiliated with the Camden and Islington Psychological Therapies Service to contact 
you for research matters. There will be approximately 33 other participants recruited 
for this study. 
 
Do I have to take part?  
 
No. Your participation in the study is entirely voluntary. It is your choice whether or 
not you would like to participate. Deciding not to take part in the study will not 
affect the care you receive from services either now or in the future. If you do decide 
to participate, you will be given this information sheet to keep, and your therapist 
will ask you to sign a consent form stating that you wish to take part. You may either 
sign this consent form and return it immediately to your therapist or bring it back to 
NHS TRUST LOGO 
Depression group participant information sheet and consent 
form 
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the psychology department within 24 hours. Alternatively, you may post it back to 
the psychology department. We will provide you with a stamp and envelope for 
postage. If you do give consent to take part in the study, you are still free to leave the 
study at any point, without giving a reason. This will not affect the care you are 
currently receiving, or will receive in the future. If you leave, any information for the 
research that we have already collected from you will be destroyed.  
 
What will happen if I decide to take part?  
 
Your psychological therapist at the clinical service will give you some details of the 
study during your first session. If you wish to take part in the study, your therapist 
will then ask you some questions to determine your eligibility to participate, as not 
everyone would be suitable. The participant information sheet will be handed to you. 
Your therapist will provide us with your contact details after you have provided 
consent to participate in the study. During a telephone call with one of our 
researchers, we will ask you some further questions to verify your eligibility. During 
this time, any other questions you may have about your participation will be 
addressed. If you decide to participate and are suitable, the researcher will arrange a 
convenient time to meet with you, preferably prior to your third therapy session with 
your therapist.  
 
If you had previously indicated your consent on an intake form, the Camden and 
Islington Psychological Services will provide the researcher with your contact 
number. The researcher will contact you to find out if you are still interested to 
participate in the study. If so, the researcher will tell you about the current study and 
ask you some questions to verify your eligibility. A copy of the participant 
information sheet will be posted to you. The researcher will phone you in about a 
week to find out if you have received the participant information sheet. If you still 
express interest in the study, the researcher will arrange a convenient time to meet 
with you.   
 
 
Study overview:  
 
The session will take approximately 70 minutes as follows: 
 
 
Arrival  
 
 
            Questionnaires         Autobiographical memorytask       Spatial memory task I  
      
 15 mins                   ~15 mins                                           ~20 mins  
 
 
 
 
 
          Spatial memory Task II      Debriefing 
              ~15 min             5 min 
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If you agree to participate in this study, you will be asked to come to a site most 
convenient for you, within the Camden and Islington NHS Foundation Trust.  Upon 
your arrival, you will meet a member of the research team and you can ask any other 
questions you may have. Following this, you will be asked to complete 
questionnaires on depression and anxiety.  The next task is an autobiographical 
memory test where the researcher will give you a number of cue words and ask you 
to recall events from the past that relate to these words. You will then perform a pen-
and-paper task (Spatial memory task I), in which you will be asked to view some 
pictures of landscapes, then select the correct answer from a few options. Spatial 
memory task II is a computerized task. You will view some scenes, then answer 
some questions to see how well you remember what you saw. Most people find these 
tasks quite interesting to do. At the end of the session, the study researcher will 
conduct a debriefing and address any other questions or concerns you may have.  
 
What are the possible disadvantages and risks for taking part?  
 
We do not anticipate any potential disadvantages or risks in your participation. 
However, we will support you if you become upset or distressed during the study. 
You will be given time at the end of the study to be fully debriefed with a member of 
the research team. Your personal therapist will also be aware of your participation in 
the study and able to support you should you find discussing your experiences 
difficult. 
  
 
What are the possible benefits of taking part?  
 
You may find it interesting to complete these tasks and the information gathered 
during this study will also help to inform our understanding of depression, which 
will hopefully be a step towards helping the development of novel screening tools in 
the future.  
 
Will I be paid for taking part in this study?  
 
We will give you £12.50 when you have completed the tasks and questionnaires to 
compensate you for your time and any travel expenses you may have incurred. 
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Who will know you are taking part in the study?  
 
We will inform your personal therapist and your GP of your participation. 
Information collected during all stages of the study will be kept strictly confidential. 
All information will only be viewed by members of the research team at University 
College London. However, if through the course of the study it was found that you 
are at immediate risk of harm to yourself or others, this information will be shared 
with your therapist or GP and if necessary, emergency services. 
 
Will my taking part in the study be kept confidential?  
 
Your consent form will be kept in a separate location from all your other data, 
ensuring that this remains anonymous. All data will be stored in secure location 
whereby a participant ID will be assigned to your data, with no identifiable personal 
information. Any data with your identifying details removed and stored on 
computers will be password protected. Any published data will also be entirely 
anonymous, meaning that individuals cannot be identified.  
 
The data from this study will be stored in accordance with the UCL and NHS Data 
Protection and Records Management policies. We will follow ethical and legal 
practice and all information about you will be handled in confidence.  
 
All data will be collected and stored in accordance with the Data Protection Act 
1998. 
 
What will happen to the results of the research study?  
 
The results will be written up in the form of reports to be submitted as a doctoral 
thesis project. As mentioned, you will not be identifiable from the results. On 
completion, you will be sent a summary of the study results if you request for it. You 
may contact one of the study researchers listed below via phone or email.  
 
What if there is a problem?  
 
Every care will be taken in the course of this study. If you wish to complain, or have 
any concerns about any aspect of the way you have been approached or treated by 
members of staff you may have experienced due to your participation in the research, 
National Health Service or UCL complaints mechanisms are available to you. Please 
ask the researcher if you would like more information on this. In the unlikely event 
that you are harmed by taking part in this study, compensation may be available.  
 
If you suspect that the harm is the result of the Sponsor’s (University College 
London) negligence, then you may be able to claim compensation. After discussing 
with the researcher, please make the claim in writing to Dr. Neil Ralph, who is the 
Chief Investigator for the research and is based at UCL. The Chief Investigator will 
then pass the claim to the Sponsor’s Insurers, via the Sponsor’s office. You may 
have to bear the costs of the legal action initially, and you should consult a lawyer 
about this.  
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Who has reviewed the study?  
 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given favourable opinion by the NRES Committee (East Midlands – Nottingham 
2).   
 
 
 
Contact Details 
 
If you wish to contact the research team to discuss any of the information further or 
any concerns you have about the study, then please do so by getting in touch with the 
members of the research team listed below:  
 
Dr John King, PhD  
Research Department of Clinical, Education and Health Psychology  
Room 440, 4th Floor  
1-19 Torrington Place, London, WC1E 7HB  
Telephone: 020 7679 5993 (x45993) 
Email: john.king@ucl.ac.uk 
 
 
Dr Neil Ralph, DclinPsy 
Research Department of Clinical, Education and Health Psychology  
Room 442, 4th Floor  
1-19 Torrington Place, London, WC1E 7HB  
Telephone: 020 7679 1621 (x41621) 
Email: n.ralph@ucl.ac.uk 
 
 
Line Sagfors 
Research Department of Clinical, Education and Health Psychology 
Email: line.sagfors14@ucl.ac.uk  
 
Janice Williams  
Research Department of Clinical, Education and Health Psychology 
Email: janice.williams@ucl.ac.uk  
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Centre Number:  
Study Number:  
Patient Identification Number for this trial:  
CONSENT FORM 
Title of Project: Understanding the Effects of Depression on Sleep and Memory 
Name of Researcher:Line Sagfors & Janice Williams  
Please initial all boxes  
4. I confirm that I have read and understand the information sheet dated 1st 
February 2016 (version 5) for the above study.  I have had the opportunity to 
consider the information, ask questions and have had these answered 
satisfactorily. 
   
5. I understand that my participation is voluntary and that I am free to withdraw 
at any time without giving any reason, without my medical care or legal rights 
being affected. 
 
6. I understand that relevant sections of my medical notes and data collected 
during the study, may be looked at by individuals from University College 
London, from regulatory authorities or from the NHS Trust, where it is 
relevant to my taking part in this research.  I give permission for these 
individuals to have access to my records. 
 
7. I agree to my GP being informed of my participation in the study.    
 
8. I agree to take part in the above study.    
 
 
 
 
 
 
NHS TRUST LOGO 
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Name of Participant   Date    Signature 
                                
            
Name of Person    Date    Signature  
taking consent.  
 
 
 
Please feel free to contact us if you have any further concerns.  
 
 
Dr John King, PhD  
Research Department of Clinical, Education and Health Psychology  
Room 440, 4th Floor  
1-19 Torrington Place, London, WC1E 7HB  
Telephone: 020 7679 5993 (x45993) 
Email: john.king@ucl.ac.uk  
 
Dr Neil Ralph, DclinPsy 
Research Department of Clinical, Education and Health Psychology  
Room 442, 4th Floor  
1-19 Torrington Place, London, WC1E 7HB  
Telephone: 020 7679 1621 (x41621) 
Email: n.ralph@ucl.ac.uk 
 
Line Sagfors 
E-mail: line.sagfors14@ucl.ac.uk 
 
Janice Williams 
E-mail: Janice.williams@ucl.ac.uk  
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APPENDIX D: LIST OF WORDS AND VALENCE RATINGS USED IN THE 
TOWN SQUARE TEST 
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Neutral and negatively valenced words used in the Town Square Test with mean 
valence ratings from Warriner et al. (2013) 
Neutral  Negative  
Word Mean valence rating Word Mean valence rating 
Barrel 4.92 Afraid 2.25 
Bedding 5.05 Anger 2.5 
Boxers 5.05 Annoy 2.49 
Brazen 5.00 Arrest 2.33 
Buckle 5.05 Attack 2.00 
Canteen 5.05 Awful 2.28 
Caving 5.00 Breakup 2.19 
Chemist 4.95 Coward 2.42 
Clinic 4.95 Creepy 2.52 
Collar 4.95 Crisis 2.05 
Column 5.00 Deadly 1.90 
Corny 5.00 Deathly 1.95 
Council 5.00 Decay 2.4 
Cunning 5.05 Dreaded 2.11 
Depend 5.00 Failure 2.15 
Fiddle 5.05 Greedy 2.10 
Forty 5.00 Harmful 2.29 
Gender 5.05 Hateful 1.90 
Goggle 5.00 Hatred 2.38 
Heady 5.00 Jealous 2.38 
Iceberg 5.05 Kidnap 2.19 
Induce 5.00 Lethal 2.48 
Ingest 5.00 Maggot 2.00 
Jigsaw 5.05 Mouldy 1.95 
Jockey 4.95 Neglect 2.16 
Kiosk 5.00 Obese 2.32 
Loosen 5.00 Perish 2.22 
Machine 5.00 Pervert 2.45 
Metal 5.05 Pimple 2.11 
Milky 5.00 Poison 2.16 
Narrow 4.95 Pollute 1.88 
Pageant 5.00 Prison 1.94 
Project 5.00 Racist 2.05 
Remark 5.05 Ransom 2.32 
Retail 5.00 Rotten 2.43 
Ringer  4.95 Sadness 2.40 
Rumble 5.00 Seasick 1.89 
Saddle 4.95 Sewage 2.33 
Sewing 5.05 Suffer 2.05 
Shorten 5.05 Suspect 2.39 
Staple 5.00 Toxic 2.35 
Storage 4.95 Traffic 2.18 
Tighten 5.00 Traitor 2.39 
Trendy 4.95 Upset 2.45 
Untie 4.95 Vandal 2.32 
Waiter 5.05 Victim 2.05 
Widen 5.00 Widow 2.28 
Wiring  5.05 Worry 2.10 
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APPENDIX E: PARTICIPANT WORD VALENCE RATING SHEET 
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Participant word valence rating sheet 
PARTICIPANT NUMBER:  
We would like to look at your responses to the words used in the study.  You will 
use a scale to rate how you felt while reading each word. The scale ranges from 1 
(unhappy) to 9 (happy). At one extreme of this scale, you are happy, pleased, 
satisfied, contented, hopeful. When a word made you feel completely happy you 
should indicate this by choosing rating 9. The other end of the scale is when you 
feel completely unhappy, annoyed, unsatisfied, melancholic, despaired, or bored. 
You can indicate feeling completely unhappy by selecting 1. Use the numbers in 
between to describe intermediate feelings of pleasure, eg if a word made you feel 
a little bit happy, score it a 6.  If you felt completely neutral, neither happy nor sad, 
select the middle of the scale (rating 5).  
Please work at a rapid pace and don’t spend too much time thinking about each 
word.  Don’t worry if you can’t remember how the word made you feel at the time, 
just rate how it makes you feel when you read it now. 
1 2 3 4 5 6 7 8 9 
Completely  
Unhappy 
   Neutral 
Neither 
happy 
or sad 
   Completely 
happy 
 
 
Word Rating 
1 = completely unhappy 
5 = neutral 
9 = completely happy 
Afraid  
anger  
annoy  
arrest  
attack  
awful  
barrel  
bedding  
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Word Rating 
1 = completely unhappy 
5 = neutral 
9 = completely happy 
boxers  
brazen  
breakup  
buckle  
canteen  
caving  
chemist  
Clinic  
Collar  
column  
Corny  
council  
coward  
creepy  
Crisis  
cunning  
deadly  
deathly  
decay  
depend  
dreaded  
failure  
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Word Rating 
1 = completely unhappy 
5 = neutral 
9 = completely happy 
Fiddle  
Forty  
gender  
goggle  
greedy  
harmful  
hateful  
hatred  
heady  
iceberg  
induce  
ingest  
jealous  
jigsaw  
jockey  
kidnap  
Kiosk  
lethal  
loosen  
machine  
maggot  
metal  
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Word Rating 
1 = completely unhappy 
5 = neutral 
9 = completely happy 
Milky  
mouldy  
narrow  
neglect  
obese  
pageant  
perish  
pervert  
pimple  
poison  
pollute  
prison  
project  
Racist  
ransom  
remark  
Retail  
ringer  
rotten  
rumble  
saddle  
sadness  
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Word Rating 
1 = completely unhappy 
5 = neutral 
9 = completely happy 
seasick  
sewage  
sewing  
shorten  
staple  
storage  
suffer  
suspect  
tighten  
Toxic  
traffic  
traitor  
trendy  
Untie  
Upset  
vandal  
Victim  
waiter  
widen  
widow  
wiring  
worry  
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Participant clinical information questions 
CLINICAL INFORMATION      
PARTICIPANT NUMBER: 
1. When did this episode/period of depression start?  
 
2. How many times have you had episodes/periods of depression before? 
 
  
3. When did you have your first episode/period of depression? 
 
 
  
4. When you have had depression in the past, which treatments have you used?  Have 
you used medication?  Have you used CBT or other talking therapies?  Did you find them 
helpful?  If so, how helpful did you find them (Improved my mood a little, improved my mood 
a lot)? 
 
Treatment type Used? Helpful? Improved a little? 
Improved a lot? 
Medication 
……………………………… 
   
CBT    
Other talking therapy 
………………………………. 
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5. Are you currently having talking therapy/CBT?  If so, how many sessions have you 
had so far?  Have you found it helpful?  If so, how helpful (Improved my mood a little, 
improved my mood a lot)? 
 
Treatment type Number of sessions Helpful? Improved a little? 
Improved a lot? 
CBT    
Other talking therapy 
………………………………. 
   
 
 
 
6. Are you on medication for depression at the moment?  If so, what is the name of the 
anti-depressant?  How much do you take every day?  How long have you been taking it for?  
Have you found it helpful?  If so, how helpful have you found it (Improved my mood a little, 
improved my mood a lot)? 
Medication name Dosage Length of time 
taken for 
Helpful? Improved a 
little? 
Improved a lot? 
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7. How long have you had depression this time?  
 
 
 
8. Do you know if anyone else in your family has or has ever had depression?  
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Participant Demographic Information Form  
Participant number:  
 
Age:  
 
Sex:  
 
How would you describe your ethnicity?  
 
 
Is English your first language?  
 
 
What is your current occupation?  
 
 
If you are currently unemployed, what was your last occupation? 
 
 
Please select the furthest level of education you have completed: 
 
 None  
  Secondary Education (GCSE/O-Levels) 
  Post-Secondary Education (College, A-Levels, NVQ3 or below, or similar) 
  Vocational Qualification (Diploma, Certificate, BTEC, NVQ 4 and above, or 
similar) 
  Undergraduate Degree (BA, BSc etc.) 
  Post-graduate Degree (MA, MSc etc.) 
 Doctorate (PhD)  
 
What is your approximate household income (before tax)? 
 
 Less than £15.000  
  £15.000-£25.000 
  £26.000-£35.000 
  £35.000-£50.000 
  £50.000-£70.000 
  £70.000 or more  
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List of abbreviations  
ANOVA Analysis of variance 
BDI-II Beck Depression Inventory  
BDNF Brain-derived neurotrophic factor 
CECA-Q Childhood Experience of Care and Abuse Questionnaire  
CT Childhood trauma 
CTQ Childhood Trauma Questionnaire 
CAPS Clinician Administered Post-Traumatic Stress Disorder Scale  
CRF Corticotropin-releasing factor  
CRH Corticotropin-releasing hormone  
CAR Cortisol awakening response 
CCAT Crowe Critical Appraisal Tool 
DHS Daily Hassles Scale 
DST Dexamethasone suppression test 
ETI Early Trauma Inventory 
GAD-7 Generalised Anxiety Disorder-7 
GR Glucocorticoid receptors  
HDRS Hamilton Depression Rating Scale 
HC Healthy controls  
HPA Hypothalamic-pituitary-adrenal axis 
IAPT Improving Access to Psychological Therapies  
IAPS International Affective Picture System  
LES Life Events Survey  
MTL Medial temporal lobe 
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MR Mineralcorticoid receptors 
NRES National Research Ethics Service 
OGM Overgeneral memory 
PHQ-9 Patient Health Questionnaire-9  
PBI Parental Bonding Instrument 
PSS Perceived Stress Scale 
pACC Perigenual anterior cingulate cortex  
PTSD Post-traumatic stress disorder 
PST Prednisolone suppression test 
PCL-C PTSD Checklist Civilian Version 
QIDS-SR Quick Inventory on Depression Symptomology  
SPSS Statistical Package for Social Sciences 
SLE Stressful life event 
SCID-I Structured Clinical Interview for DSM Disorders  
TIPI Ten Item Personality Inventory 
UCL University College London 
 
  
 
